Design and evaluation of a prosthetic anterior cruciate ligament replacement medical device by Bach, Jason Samuel
DESIGN AND EVALUATION OF A PROSTHETIC ANTERIOR CRUCIATE LIGAMENT 

















In Partial Fulfillment 
of the Requirements for the Degree 





Georgia Institute of Technology 
May 2012
DESIGN AND EVALUATION OF A PROSTHETIC ANTERIOR CRUCIATE LIGAMENT 








David Ku, M.D., Ph.D.  
Department of Mechanical Engineering 
Georgia Institute of Technology  
 
Robert Guldberg, Ph.D.  
Department of Mechanical Engineering 
Georgia Institute of Technology  
Mohammed Cherkaoui, Ph.D. 
Department of Mechanical Engineering 
Georgia Institute of Technology 
Rudolph Gleason, Ph.D.  
Department of Biomedical Engineering 
Georgia Institute of Technology  
 
Laurent Corté, Ph.D.  
Centre des Matériaux 
















I would like to thank my advisor, Dr. Ku, for his guidance and support during my 
time at graduate school.  His experience, knowledge, and insight were invaluable and 
made completion of this thesis work possible.  His patience, affability, and hospitality 
were much appreciated. I am grateful for the opportunity to have worked in his laboratory 
with an advisor caring so much for the wellbeing his students.  Additionally, I would like 
to thank my co-advisor, Dr. Cherkauoi, for his support, assistance, and guidance, and 
our collaborator, Dr. Corté, who provided a great amount of input related to the project 
and graciously allowed us access to his laboratory and testing machines making the 
mechanical evaluation possible.  My other committee members, Dr. Guldberg and Dr. 
Gleason are also appreciated for their advice and input.   
Other contributors worthy of recognition include the post-docs, Dr. Detrez, Dr. 
Baxter, and Dr. Richter, for their help with different aspects of this project.  I would also 
like to thank Dr. Garrett, Dr. Cuny, Dr. Vergnant, and Dr. Karas, orthopedic surgeons 
with a wealth of knowledge and experience, who graciously allowed us to meet with 
them and provided invaluable advice from a clinical standpoint.  My wife, Vicki, deserves 
special recognition as it was her careful and nimble fingers which assembled all the 
samples for mechanical testing.  Finally, I’d like to thank the rest of my family for their 
love and support and the joy of having them as a part of my life. 
iv 
 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS ............................................................................................... iii 
LIST OF TABLES ......................................................................................................... viii 
LIST OF FIGURES ......................................................................................................... ix 
SUMMARY ................................................................................................................... xiii 
CHAPTER 1 Introduction ............................................................................................ 1 
1.1 Anterior cruciate ligament – anatomy and function ........................................... 1 
1.2 ACL rupture and current reconstruction options ............................................... 1 
1.3 Developing a prosthetic alternative ................................................................... 4 
1.4 References ....................................................................................................... 6 
CHAPTER 2 Design Considerations for a Prosthetic Anterior Cruciate Ligament ....... 8 
2.1 Introduction ...................................................................................................... 8 
2.2 ACL reconstruction ........................................................................................... 9 
2.3 Biological grafts ...............................................................................................11 
2.4 Prosthetics as an alternative ...........................................................................11 
2.5 Design control process ....................................................................................15 
2.6 Design inputs ..................................................................................................17 
2.7 Design considerations .....................................................................................23 
2.8 Proposed solution ............................................................................................25 
2.9 Risk analysis ...................................................................................................27 
2.10 Verification testing ...........................................................................................29 
v 
 
2.11 Discussion .......................................................................................................31 
2.12 References ......................................................................................................32 
CHAPTER 3 Mechanical Evaluation of Materials and Rope Structures for an Anterior 
Cruciate Ligament Prosthesis ........................................................................................42 
3.1 Introduction .....................................................................................................42 
3.2 Methods ..........................................................................................................44 
3.2.1 Materials selection ....................................................................................44 
3.2.2 Design considerations and process overview ...........................................45 
3.2.3 Rope analysis ...........................................................................................45 
3.2.4 Rope preparation......................................................................................53 
3.2.5 Braid computational analysis ....................................................................55 
3.2.6 Static tensile testing .................................................................................55 
3.2.7 Long-term mechanical testing ..................................................................56 
3.3 Results ............................................................................................................57 
3.3.1 Study 1: Material evaluation .....................................................................57 
3.3.2 Study 2: Effect of rope pattern ..................................................................59 
3.3.3 Study 3: Effect of hollow braid parameters ...............................................61 
3.3.4 Study 4: Long-term evaluation ..................................................................64 
3.4 Discussion .......................................................................................................67 
3.5 Conclusion ......................................................................................................71 
3.6 References ......................................................................................................71 
vi 
 
CHAPTER 4 Augmentation of Bone Tunnel Healing in Anterior Cruciate Ligament 
Grafts: Application of Calcium Phosphates and Other Materials ....................................75 
4.1 Introduction .....................................................................................................75 
4.2 Bone Tunnel Healing in ACL Replacement......................................................76 
4.2.1 ACL Anatomy and Injury...........................................................................76 
4.2.2 ACL Replacement ....................................................................................76 
4.2.3 Bone Tunnel Healing ................................................................................79 
4.2.4 Assessment Techniques for Bone Tunnel Healing ...................................80 
4.3 Calcium Phosphates .......................................................................................81 
4.3.1 Calcium Phosphates as Biomaterials .......................................................81 
4.3.2 Calcium Phosphates in ACL Reconstruction ............................................83 
4.4 Alternative Augmentation Materials .................................................................93 
4.4.1 Soft Tissue Grafts.....................................................................................93 
4.4.2 Artificial Grafts ..........................................................................................97 
4.5 Discussion .......................................................................................................99 
4.5.1 Test Methodologies ..................................................................................99 
4.5.2 CaPs for Bone Tunnel Healing ............................................................... 100 
4.5.3 Application to Artificial Graft Materials .................................................... 102 
4.6 Conclusions ................................................................................................... 102 
4.7 References .................................................................................................... 103 
CHAPTER 5 Kinematic Evaluation of Anterior Cruciate Ligament Reconstruction with 
a Synthetic Prosthesis ................................................................................................. 109 
vii 
 
5.1 Introduction ................................................................................................... 109 
5.2 Methods ........................................................................................................ 112 
5.2.1 Building the knee models ....................................................................... 112 
5.2.2 Model validation ..................................................................................... 114 
5.2.3 Kinematic evaluations of reconstructed knees ........................................ 115 
5.3 Results .......................................................................................................... 116 
5.3.1 Validation ............................................................................................... 116 
5.3.2 Study 1: Ideal tension for restoration of anterior laxity ............................ 119 
5.3.3 Study 2: Effects of changes in tension on anterior laxity ......................... 120 
5.3.4 Study 3: Effect of tunnel orientation on rotational stability and stress 
concentrations ...................................................................................................... 122 
5.3.5 Study 4: Effect of toe region presence .................................................... 124 
5.4 Discussion ..................................................................................................... 127 
5.5 Conclusion .................................................................................................... 130 
5.6 References .................................................................................................... 130 
CHAPTER 6 Conclusion .......................................................................................... 135 
6.1 Summary and significance ............................................................................ 135 
6.2 Alternative solutions ...................................................................................... 138 
6.3 Limitations ..................................................................................................... 139 
6.4 Future directions............................................................................................ 140 
6.5 References .................................................................................................... 142 
APPENDIX .................................................................................................................. 145 
viii 
 
LIST OF TABLES 
Table 2.1   The Design Inputs for a next generation prosthetic ACL along with associated 
verification and validation tests. ..................................................................22 
Table 3.1  Mechanical design inputs for a prosthetic ACL. .............................................43 
Table 3.2   Mechanics design inputs with verification test results ...................................64 
Table 4.1   Mechanical testing of different augmentation methods using calcium 
phosphates for bone tunnel healing.. ..........................................................83 
Table 4.2   Mechanical testing of various augmentation methods for bone tunnel healing.
 ...................................................................................................................93 
Table 5.1   Range of tensioning for prosthetic placement resulting in restoration of 
anterior tibial restraint within one standard deviation of the native ACL and 
currently used autograft reconstructions.................................................... 122
ix 
 
LIST OF FIGURES 
Figure 2.1  Transtibial (A) and Anteromedial portal (B) drilled femoral tunnel orientations
 ...................................................................................................................10 
Figure 2.2   Design Control Process. Adapted from FDA guidance document. ..............16 
Figure 2.3   A fault tree diagram for a prosthetic ACL.  Failure modes are traced back to 
root causes which can be countered as a part of the design process. .........28 
Figure 3.1   Force vs. strain relationship for the native ligament shown alongside patellar 
tendon graft and double-looped hamstring graft. .........................................44 
Figure 3.2   Ideal geometry of a twisted yarn (left) and flattened projection of one 
filament over one helical turn (right). ...........................................................46 
Figure 3.3   Idealized geometry of a 4-strand square braid (left) and magnification of one 
square braid unit cell (right). ........................................................................49 
Figure 3.4   One UHMWPE thread (top) and one PVA cord (bottom) ............................57 
Figure 3.5   Force versus strain relationship for one saturated PVA cord and one 
saturated UHMWPE thread. ........................................................................58 
Figure 3.6   Force versus strain relationships for a twisted bundle of 16 PVA cords, and 
the same twisted along with 12 UHMWPE threads compared with the native 
ACL and hamstring autograft. .....................................................................59 
Figure 3.7   Twisted, 4-strand square square braided, and hollow braided samples. .....60 
Figure 3.8   Force versus strain relationship for twisted, 4-strand square braided, and 
hollow braided specimens compared to the native ACL and hamstring 
autograft. .....................................................................................................61 
Figure 3.9   Hollow braid geometrical parameters include the helix angle (θ0), 
circumferential braid dimension (X0), longitudinal braid dimension (Y0), and 
core diameter. .............................................................................................62 
x 
 
Figure 3.10  Force versus strain relationships for hollow braided samples with 8, 12, and 
16 PVA cords in the core shown with the native ACL and hamstring 
autograft. .....................................................................................................63 
Figure 3.11  Predicted and experimentally measured force versus strain relationship for 
hollow braids with 16 PVA cords in the core and helix angles of 40°, 45°, 
50°, and 55° shown with the native ACL and hamstring autograft. ..............64 
Figure 3.12  Samples at the first cycle, after 300,000 cycles, and after 1 million cycles of 
loading.  Note the minor progression of PVA fraying over the course of cyclic 
loading. .......................................................................................................65 
Figure 3.13  Load versus deformation curves over the course of cyclic loading. ............66 
Figure 3.14  Deformation from the application of 50 N and 450 N over the course of 
cyclic loading.  Deformations are calculated relative to the length at the first 
cycle with the application of 50 N. ...............................................................66 
Figure 4.1   The anatomy of the bones of the knee showing the position of the bone 
tunnels from (a) frontal and (b) lateral views. The patella and patellar 
tendons are omitted for clarity. ....................................................................78 
Figure 5.1   Coronal and sagittal views of transtibial (A) and anteromedial (B) 
reconstructions. ......................................................................................... 114 
Figure 5.2   The single-axis force versus strain behavior for the nonlinear and linear 
prostheses tested shown alongside that of the native ACL.  Curves are 
shown up to 700 N force. .......................................................................... 116 
Figure 5.3   Simulated AMB and PLB length changes shown alongside experimental 
results from Amis and Dawkins.  Error bars represent one standard deviation 
for the experimental data. ......................................................................... 117 
xi 
 
Figure 5.4   Simulated resultant force as a function of flexion angle shown alongside 
experimental results from Wascher et al.  Error bars indicate the 
approximate range of values reported from the experimental data. ........... 117 
Figure 5.5   Simulation and experimental measurements of ATT in response to 134-N 
anterior tibial load applied to ACL-intact and ACL-deficient knees.  
Experimental results are shown as mean ± standard deviation from Yagi et 
al. .............................................................................................................. 118 
Figure 5.6   Simulation and experimental measurements of anterior tibial translation in 
response to combined rotary loading of 10-Nm valgus torque and 4-Nm 
internal tibial torque.  Experimental results are shown as mean ± standard 
deviation from Zantop et al. ....................................................................... 119 
Figure 5.7   ATT in response to 134-N anterior tibial load in simulated transtibial and 
anteromedial prosthetic reconstructions with the ideal tension of 10 N for 
transtibial and 0 N for anteromedial implantations shown with simulated ACL 
intact and deficient controls. ...................................................................... 120 
Figure 5.8   ATT in response to 134-N anterior tibial loading with prosthetics placed at 
varying levels of extension and slack in the transtibial orientation shown 
alongside simulated ACL-intact and ACL-deficient controls.  The shaded 
area covers the range within one standard deviation of the intact knee and 
currently accepted ACL replacements from an experimental study by Yagi et 
al. .............................................................................................................. 121 
Figure 5.9   ATT in response to 134-N anterior tibial loading with prosthetics placed at 
varying levels of extension and slack in the anteromedial orientation shown 
alongside simulated ACL-intact and ACL-deficient controls.  The shaded 
area covers the range within one standard deviation of the intact knee and 
xii 
 
currently accepted ACL replacements from an experimental study by Yagi et 
al. .............................................................................................................. 122 
Figure 5.10  ATT in response to combined rotary loading of 10-Nm valgus torque and 4-
Nm internal tibial torque on simulated transtibial and anteromedial prosthetic 
reconstructions shown alongside simulated ACL-intact and ACL-deficient 
controls. .................................................................................................... 123 
Figure 5.11  Maximum principal stresses in the device occurring at full extension in the 
transtibial (TT) and anteromedial (AM) orientations.  Inset shows maximum 
prosthetic bending angle in both orientations, which occurred at full knee 
extension. ................................................................................................. 124 
Figure 5.12  Simulated results comparing ATT produced in response to a 134-N anterior 
tibial load in knees reconstructed with linear and nonlinear prosthetic ACL.  
Results are shown alongside simulated ACL-intact and ACL-deficient 
controls. .................................................................................................... 125 
Figure 5.13  Maximum principle stresses arising in linear and nonlinear prosthetics in the 
transtibial orientation over the range of knee flexion from 0° to 90°. .......... 126 
Figure 5.14  Maximum principle stresses arising in linear and nonlinear prosthetics in the 





Rupture of the anterior cruciate ligament (ACL) is a relatively common sports-
related injury for which the current treatment is reconstruction with an autograft or 
allograft.  Drawbacks associated with each of the current options would make a 
prosthetic alternative advantageous, however, artificial ligaments are not widely used, 
having failed due to lack of biocompatibility and mechanical insufficiencies.  To develop 
the next-generation prosthetic ACL, design control principles were applied including 
specification of comprehensive design inputs, risk analysis, and verification testing.  A 
design was proposed utilizing polyvinyl alcohol and ultrahigh molecular weight 
polyethylene, selected for good biocompatibility and mechanical strength and stiffness 
suitable for ACL replacement.  A biomimetic fibrous rope pattern was designed for the 
intra-articular ligament section of the prosthetic that produced a close match the static 
tensile behavior of the native ACL and which also demonstrated good resistance to 
fatigue and creep.  A calcium phosphate coating was recommended for the sections of 
the device lying within the bone tunnel to increase the rate of osseointegration.  The 
proposed design was then evaluated in a computational simulation to assess functional 
restoration and the effects of installation parameters such as tension and tunnel 
orientation on knee kinematics.  The encouraging results of preclinical verification testing 




CHAPTER 1   Introduction 
1.1 Anterior cruciate ligament – anatomy and function 
Ligaments are soft-tissue structures that connect bones to other bones forming a 
joint.  The anterior cruciate ligament (ACL) resides within the knee and extends from a 
posterior position on the medial wall of the lateral femoral condyle to an insertion at the 
anterior part of the central tibial plateau. As a tensile load bearing structure, the ACL 
functions as the primary restraint to anterior translation of the tibia relative to the femur 
and also has a secondary role in limiting internal tibial rotation. It is a critical component 
for the stabilization of the knee joint throughout its range of motion.[1-2]  
The ACL is a band-like structure of dense connective tissues, irregular in shape 
with a length ranging from 22 to 41 mm and a width from 7 to 12 mm.[1]  Native ACL is 
comprised of crosslinked, parallel collagen bundles (types I, III, and V), water, elastin, 
proteoglycans, and cells.[2] The collagen fibers provide high tensile strength, 
withstanding cyclic loads between 0 and 450N on the order of one million cycles per 
year.[3-5] The maximum load and linear stiffness of the native ACL has been reported to 
be from 1725 to 2160 N and from 182 to 292 N/mm, respectively.[6-8] The Young’s 
modulus of human ACL is 111 MPa and the ultimate tensile strength is at least 38 
MPa.[9-10] A periodic crimped pattern along the length of the collagen fibers results in a 
low stiffness toe region at low levels of strain.[5] 
1.2 ACL rupture and current reconstruction options 
ACL rupture is the most common knee ligament injury and is most often caused 
by the sudden twisting of the knee in a weight bearing position.[11]  Annually, 
approximately 1 in 3000 Americans experience anterior cruciate ligament injury.[12-13] 
Approximately 50,000 ACL reconstructions are performed each year in the United States 
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at an average cost of $17,000 per procedure corresponding to a total financial impact of 
nearly 1 billion dollars.[14] The untreated ruptured ACL can result in knee pain, loss of 
stability, increase risk of meniscal injury, and an accelerated onset of osteoarthrosis.[11-
12]  
Unlike collateral knee ligaments which heal after injury and generally respond 
well to conservative treatment, the ACL does not heal when torn, because it lacks 
significant vascularization and has a limited blood supply.  Damage to its surrounding 
synovial lining leads to blood dissipation within the joint preventing formation of a local 
hematoma.[12]  Therefore, surgical reconstruction is the standard treatment for ACL 
rupture, in which a ligament replacement is secured between tunnels drilled into the 
femur and tibia.[15]  Fixators, such as screws, buttons, or crosspins, are used to attach 
the ends of the ligament replacement within the bone tunnels at the time of surgery and 
over time these tunnel sections of the replacement integrate with the surrounding 
bone.[16]  The aims of reconstruction are to restore the kinematics and stability of the 
injured knee and also to prevent future degenerative changes.[15] Patients with ACL 
injuries tend to be younger and more active than other orthopedic patients, and 
therefore, reconstructions should exhibit good longevity, withstanding high stresses over 
millions of cycles.[17] 
Autologous graft substitutes, or autografts, come from the patient’s own body and 
provide advantages such as the presence of stretch receptors, vascularity, and the 
absence of graft rejection issues.  The bone-patellar tendon-bone (BPTB) and the 
double-looped semitendinosus/gracilis tendon (DLSGT) hamstring autografts (also 
called quadrupled hamstring grafts) are the most popular types of autografts, used in 
over 90% of ACL reconstructions.  The quadriceps tendon and iliotibial band have also 
been used as graft sources though are not as common.[1, 17]  Problems with these 
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grafts include post surgical knee pain, flexion contracture, and crepitation. Issues 
relating to donor site morbidity, specifically arthrofibrosis, patello-femoral pain when 
kneeling, quadriceps weakness, and loss of sensitivity associated with BPTB grafts have 
caused a gradual shift away from their use to the DLSGT grafts in recent years.[1]  
Overall donor site morbidity with hamstring grafts is generally less than with the patellar 
tendon grafts, however saphenous nerve damage and hamstring weakness have been 
reported.[18] Other disadvantages of autograft reconstructions include longer operation 
and recovery times due to the necessity of the additional harvesting procedure. 
The use of allografts, made from the tissue of a cadaver, circumvents the 
problem of donor site morbidity; however, is associated with other drawbacks including 
risk of immunological rejection and disease transmission, delayed biological 
incorporation, and a limited supply of donor tissue.[17] Allografts cannot be sterilized 
completely without compromising their mechanical properties, and are, therefore, either 
more susceptible to failure or associated some risk of disease transmission.[17, 19] 
Increasing demand and a low supply of young healthy cadaver donors with low risk 
lifestyles have resulted in a shortage of allograft tissues, making allografts very 
expensive, costing from $2000 to $10,000 each in addition to the cost of the procedure.  
Surgeons have also been forced to use alternative cadaveric tissues such as the 
Achilles tendon, and the anterior tibialis and posterior tibialis tendons due to this lack of 
availability.  Additionally, many surgeons do not have ready access to allograft 
procurement and processing facilities.  Allografts are more often used in repeat 
reconstructions when autografts are no longer available for harvest.[17]   
Artificial ligaments have been proposed as an alternative to overcome the 
shortcomings of biological grafts.  Past devices have been made from a wide range of 
materials including carbon fibers, polytetrafluoroethylene, polyethylene terephthalate, 
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polyester, polyurethane urea, and polypropylene, none of which have been able to 
provide satisfactory long term results due to mechanical and biocompatibility 
insufficiencies.[11] The use of carbon fiber, Dacron, or polypropylene fiber yarn 
prostheses is associated with chronic inflammation and the generation and migration of 
wear particles in the joint space and lymph nodes.  Excessive creep, wear damage, 
fatigue, and high rates of rupture leading to persistent joint laxity have also been 
reported several years after implantation with carbon fiber, polytetrafluoroethylene, 
polyethylene terephthalate, and polyurethane urea prosthetics. Autografts and allografts 
have consistently been more durable and resistant to mechanical failure than the many 
biomaterials used to make prosthetics.[17] 
Tissue engineering an ACL by culturing progenitor ligament cells on a matrix 
scaffold is currently in the research phase.  This approach would involve seeding the 
scaffold with ACL fibroblast progenitor cells and applying mechanical loading and 
chemical cues to stimulate the cells and tissue to mature in the correct orientation, 
replicating a normal ACL’s structure and geometry. Current results of histological studies 
on tissue engineered ligaments indicate that neoligamentous ingrowth occurs, however 
mechanical testing of the new tissue reveals insufficient strength and stiffness, often by 
one or more orders of magnitude.  Challenges associated with regenerating ligaments 
with the collagen organized in the appropriate orientation to provide the specific 
mechanical response requirements will prevent such treatment options from reaching 
clinical implementation in the near future. 
1.3 Developing a prosthetic alternative 
The focus of this thesis is the development of a next generation ACL 
replacement, free from the problems associated with currently used treatment options, 
made possible with recent advances in biomaterials and understanding of knee and 
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ligament biomechanics.  The ACL replacement will need to sufficiently match the 
mechanical properties of the native ACL in terms of strength, elasticity, and durability 
without excessive creep and fatigue or side effects such as immunogenic particulation.  
Furthermore, the device should preserve the kinematics of the native ACL, provide the 
needed knee stability, and limit wear in the joint to reduce the progression of 
osteoarthritis.  
Each of the following chapters addresses a different aspect of the development 
of the device. Chapter 2 describes the design considerations as a whole within the 
context of a structured, medical device-focused design control process.   
Comprehensive design inputs for the device are specified together with appropriate 
verification tests.  A risk analysis and design recommendations are also presented.  
Chapter 3 focuses on the intra-articular section of the prosthetic and how to reproduce 
the unique mechanical behavior of the ligament.  Fibrous materials and rope structures 
are first tested in tension to converge upon a design that produces the correct static 
response.  Then, the design is subjected to cyclic loading to test long-term behavior, 
specifically the resistance to fatigue and permanent elongation.  Chapter 4 focuses on 
the bone tunnel sections of the device and reviews some potential strategies and 
substances used to improve healing and osseointegration such the calcium phosphates, 
various growth factors, cells, and periosteum.  Previous studies on the effectiveness of 
these bioactive materials were compared to determine which, if any, would be 
advantageous to incorporate into the design of the prosthetic.  Chapter 5 moves beyond 
the device design phase to a functional evaluation of the device in a knee model.  
Simulated kinematic tests were executed to measure functional restoration provided by 
the device and predict in vivo stress concentrations.  The effects of tunnel orientation 
and device tension were also assessed so that recommendations could be offered 
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regarding how the device should be installed. Together, these chapters aim to provide 
adequate preclinical evidence for feasibility and design verification to proceed with 
clinical evaluation.  Chapter 6 concludes the thesis by highlighting the significance and 
potential impact of this research and outlining the next stages of product development 
and the requirements for market entry.   
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CHAPTER 2   Design Considerations for a Prosthetic Anterior Cruciate Ligament 
2.1 Introduction 
The anterior cruciate ligament (ACL), one of the four major ligaments in the knee, 
is a critical component for the maintenance of proper tibiofemoral orientation, knee 
motion, and knee stability.[1-2].  The ACL extends from a posterior position on the 
medial surface of the lateral femoral condyle to a more medial and anterior position on 
the tibial plateau. In this orientation, the ligament acts as a tensile load bearing structure, 
resisting excessive anterior translation of the tibia relative to the femur.   
The mechanical behavior of the native ACL, the determining factor influencing its 
function within the knee, is derived from the material composition and structural 
organization of the tissue.  Extracellular matrix (ECM) comprises approximately 80% of 
the ligament by volume.[3] The ligament ECM can be modeled as a fiber-reinforced 
composite structure, in which multiple, densely packed, bands of collagen fibers are 
aligned axially in parallel, embedded within a hydrophilic ground substance.[2, 4-8]  The 
collagen fibrils, which constitute approximately 75% of the dry weight of the ligament, 
provide high ultimate strength and exhibit a periodic, crimped pattern resulting in 
nonlinear, strain-hardening behavior: the ligament deforms easily at low strain in the so-
called “toe” region which is followed by greater stiffness at higher strain. [1-2, 4]     
ACL rupture is a relatively common sports injury, which can occur when the knee 
is subjected to combined twisting and compressive forces, when the knee is 
hyperextended, or when an external force is applied in the anterior direction on the tibia. 
[9-10]  ACL injuries have been observed across the mid-substance of the ligament, at 
the interface between the ligament and bone, or in the bone close to the ligament 
9 
 
attachment site.[10]  Ligament damage often results in excessive anteroposterior laxity 
and knee instability.[11-12]   
2.2 ACL reconstruction 
Due to sparse vascularization and low blood supply, the torn adult ACL has not 
been observed to heal without treatment or with primary repair.[4, 13]  Consequently, the 
current treatment options are limited to reconstructions, where a ligament-replacing 
autograft or allograft is installed between the femur and tibia, fixated within bone tunnels, 
with the primary goal of providing stability and restoring function to the knee.[14]  
Approximately 175,000 ACL reconstructions performed each year in the United States at 
a cost exceeding $2 billion.[15-17]  A meta-analysis of the clinical results of ACL 
reconstruction reveals that 64% to 75% of patients return to pre-injury levels of activity 2-
years post-operation.[18]  The prevalence of re-rupture failure is reported to be 3-4% 
with an additional non-rupture complication rate of 12%.[18] 
The femoral tunnel can be drilled transtibially or through an auxiliary 
anteromedial portal.[19]  Placement of the transtibially drilled femoral tunnel is 
constrained by the fact that it must be collinear with the tibial tunnel with the knee at the 
position at which it is drilled, commonly at 90° of knee flexion.[20]  If the femoral tunnel is 
drilled transtibially, the resulting position of the graft is more vertical, and the femoral 
tunnel entrance tends to lie towards the roof of the notch, anterior to the footprint of the 
native ACL.[20]  Grafts suspended from transtibially drilled tunnels may be effective at 
resisting excessive anterior tibial translation, however, are more likely to result in positive 
pivot shift and greater rotational laxity.[21-23]  An alternative is the anteromedial portal 
technique where the tibial and femoral tunnels are drilled independently, the latter from 
an auxiliary anteromedial portal at the medial side of the patella with the knee at 110° to 
130° flexion.[24]  This anteromedial technique results in a more lateral position for the 
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femoral tunnel entrance closer to the center of the native footprint improving rotational 
stability.[21-22, 25] 
 
Figure 2.1  Transtibial (A) and Anteromedial portal (B) drilled femoral tunnel 
orientations 
An autograft or allograft is attached to the bone tunnels at the time of installation 
with some type of fixation device, which may vary with the graft type, tunnel placement, 
patient-specific knee characteristics, and surgeon preference.[26-28]  Cross-pins and 
buttons are examples of suspensory types of fixations, where the graft is secured closer 
to the extra-articular end of the tunnel away from the joint.[29]  Alternatively, interference 
screws may be used to fix the graft at the aperture near the intra-articular space.[28]  
The initial fixator must provide sufficient strength to support the graft from the time of 
installation until the completion of osseointegration.[30]  The rehabilitation protocol is 
designed to protect the joint early on by limiting knee activity to operations producing 
loads not exceeding the graft fixation strength until stronger integration with the bone 
forms over time.[30] 
11 
 
2.3 Biological grafts 
Autograft reconstruction is a popular option in which a section of the patient’s 
own tissue is harvested and utilized as a ligament replacement, most commonly from the 
patellar tendon or hamstrings.  Autografts have several drawbacks.  Donor site morbidity 
such patellar fracture, nerve damage, infection, and soreness are reported by 40% to 
60% of patients in the years following autograft reconstruction.[31]  Additionally, the 
requirement of the harvest procedure in addition to the installation procedure increases 
the total operation time and cost.[32] 
Allografts, harvested tissue from a cadaver, are also used for ACL 
reconstructions as an alternative to autografts.  Allograft usage precludes donor site 
morbidity and the necessity of the harvest operation, however is associated with other 
drawbacks.  The use of allografts results in abnormal knee stability in approximately 
14% of cases versus only 5.3% with autografts, as defined by the International Knee 
Documentation Committee (IKDC).[33]  Allografts are also slower to incorporate within 
the bone tunnels.[33-35]  Furthermore, allografts are associated with a disease 
transmission rate as high as 4%.[36]  A 2002 publication from United States Centers for 
Disease Control and Prevention (CDC) reports 26 cases of infection from allografts and 
one fatality from Clostridium sordellii contamination.[37]  Seventy cases of infection were 
further reported in a 2004 CDC report.[38] 
2.4 Prosthetics as an alternative  
A synthetic prosthetic device to replace the ACL would be advantageous as it 
would preclude the donor site and infectious problems associated with the biological 
grafts.  Operation times would be reduced and the operation made less invasive relative 
to autograft reconstructions, since the harvest procedure would not be required.  By 
eliminating the need for additional operating room time, anesthesia, and an overnight 
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stay in the hospital, the cost of the procedure could be reduced by more than $1,000.[32]  
Additional costs associated with the use of allografts include more expensive fixation 
and the price of the graft itself, which together can exceed $750.[32]  After the operation, 
biological grafts undergo collagen remodeling, during which the mechanical properties of 
the graft change extensively, with strength and stiffness reducing by 50 to 80 percent 
after six weeks before slowly increasing to restore functional laxity over the next 24 to 52 
weeks.[39-40] A prosthetic device can be designed to retain its strength and stiffness in 
the early weeks and therefore may not require as long a time for recovery.[40]  There 
have been three general approaches to reconstruction of the ACL using polymeric 
materials.[41]  Frank replacement type prostheses are designed to permanently replace 
the ACL.  Stents, also called ligament augmentation devices (LADs), are designed to 
protect autografts during the earlier stages of revascularization and maturation.  Finally, 
scaffold type devices aim to provide support for new, regenerated or engineered tissue.   
The earliest record of reconstruction of the ACL with a non-biological graft was F. 
Lange’s attempt with silk braids in 1903 which failed quickly.[42]  In subsequent years, 
metal wires, nylon, silk, and other materials were suspended in place of the ligament, but 
recurring mechanical failures and lack of biocompatibility limited such development to 
the animal testing stage.[43] A newer generation of prosthetics were developed from the 
1970s through the 1990s, made from a wide range of materials including carbon fiber, 
polytetrafluoroethylene, polyethylene terephthalate, and polypropylene.[44] In the late 
1980’s the United States Food and Drug Administration (FDA) approved the Gore-Tex 
(W.L. Gore, Flagstaff, Arizona) and Stryker-Meadox Dacron (Meadox Medical, Oakland, 
New Jersey) frank replacement devices, as well as the Kennedy LAD (3M, St. Paul, 
Minnesota); however, none of these are currently used.[45]   
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Carbon fiber was explored as a possible material for ACL replacement, but was 
observed to fragment and appear in the regional lymph nodes.[46]  The ABC prosthetic 
ligament (Surgicraft Ltd., Redditch, UK), consisting of carbon fiber and polyester, had 
unacceptably high rates of creep and complete rupture leading to poor results.[47]  Good 
Lysholm scores, defined as greater than 76 out of 100, were achieved in only 41% of 
patients after 1 to 3 years.[47]  The Stryker-Meadox Dacron graft, made of polyester with 
a velour coating, failed to maintain knee stability in 40% to 60% of patients after 4 years 
as assessed by pivot shift, side-to-side laxity, anterior drawer, and Lachman test.[48-49]  
Failures were attributed to elongation due to creep and ruptures occurring at the femoral 
insertion, tibial insertion, and the central body of the graft.[50]  The Gore-Tex graft, made 
of expanded polytetrafluoroethylene, had good initial results, but were later observed to 
cause four types of failures: (1) effusions and chronic synovitis from particulate debris or 
disrupted exposed fibers, (2) graft rupture after cyclic loading, most commonly on the 
femoral side, (3) loss of tension related to osteolysis and bone tunnel enlargement, and 
(4) infection.[51]   
The polyester Leeds-Keio artificial ligament was designed to act as a scaffold for 
neoligamentous ingrowth.[52]  The device, having an ultimate load of approximately 
2100 N, close to that of the native ACL, performed well early on, but did not have 
adequate fatigue resistance beyond the first post-operative year.[44, 53]  Long term 
studies indicated fibrous tissue ingrowth was not properly aligned to restore ligament 
function; therefore, loads continued to be carried by the Leeds-Keio prosthesis, resulting 
in high rates of rupture.[53-54]  The Kennedy LAD was made of polypropylene and 
designed to support an autogenous graft.[55]  Use of polypropylene resulted in reactive 
synovitis and inflammation accompanied by the proliferation of foreign body giant cells 
and macrophages.[56]   
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The Ligament Advanced Reinforcement System (LARS) (Arc-sur-Tille, France) is 
a newer artificial ligament made of polyethylene terephthalate (PET) with free fibers in 
the intra-articular section of the device which are arranged in parallel longitudinally, 
twisted to the left or right depending upon the knee side mimicking the native ACL fiber 
orientation.[57]  The LARS is designed to resist torsional fatigue by reducing shear 
stresses, which are proportional to the radial distance from the axis of rotation.[57]  The 
radial distance is smaller within free independent fibers than in a construct of fibers 
forced to twist together as a single larger unit. Additionally, the use of free fibers reduces 
inter-fiber wear by eliminating the points where fibers cross over and rub against each 
other.[57] The LARS device has been evaluated in several studies which report high 
patient satisfaction up to five years after implantation.[58]  Mechanical failures of the 
PET ligament or the fixating screws occur in from 4% to 8% of LARS 
reconstructions.[58]  Other complications that have been observed include superficial 
wound infection, pain from the screws, and, in one case, synovitis.[58]   Despite their 
long history, prosthetic devices are not widely used currently due to the prevalence of 
associated mechanical and lack of biocompatibility.[44]   
In recent years, interest has grown in tissue-engineered alternatives, which 
would, in theory, be able to remodel over time as is the case with the native 
ligament.[44]  Tissue engineering of the ligament requires a scaffold which can be 
seeded with fibroblast or mesenchymal stem cells, and subsequently support 
neoligamentous growth in an ex vivo bioreactor prior to implantation, or in vivo, providing 
function in the knee upon implantation and progressively biodegrading at a rate 
complementary to tissue ingrowth.[59]  Scaffolds have been created from biological 
polymers such as collagen and silk fibroin as well as biodegradable synthetics such as 
poly L-lactic acid (PLLA), poly-caprolactone, and polycarbonate.[44, 60-62]  Currently, 
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these types of scaffolds have been shown to be capable of supporting cellular adhesion, 
growth, and matrix deposition if they are supplied with an appropriate combination of 
growth factors and mechanical stimulation.[63]   However, the precise regimen of cell-
specific growth factors, nutrients, metabolites, and the correct physical and dynamic 
mechanical environment required to grow properly structured ligament tissue have not 
yet been found.  While promising, none of the tissue-engineered constructs have been 
shown to possess adequate strength or architecture for functional restoration in vivo.[59, 
63]   
The failure modes of previous devices can be addressed within the design 
control process and risk analysis to improve performance in the next generation ACL 
prosthesis.  Many of the previous devices were susceptible to fatigue and permanent 
elongation within several years of installation.[44]  Damage from fiber abrasion against 
the bone surface and flexural fatigue have also been observed.[64] Additionally, 
particulation generated from prosthetics has been known to cause an undesirable 
immunogenic, inflammatory response.[65-66]  New ACL prosthetic devices should be 
designed with features mitigating each of these undesirable effects.  
2.5 Design control process 
Design Controls are required by the FDA in the United States and ISO for 
European regulatory clearance.[67-68]  Design Controls are a systematic set of 
processes and procedures used to ensure that a device is developed and engineered to 
meet design requirements and is appropriate for its intended use.  The system enables 
designers to iteratively converge upon a suitable design while recognizing and correcting 
deficiencies in the early stages of the development process.  First, user and patient 
needs are assessed to identify all device requirements and establish the desired 
features, which may provide a competitive advantage over existing options.  When 
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possible, these needs are compiled and specified in detail becoming the Design Inputs. 
The acceptable ranges of values for each of the design inputs are stipulated along with 
appropriate verification and validation tests.  The design inputs are reviewed at each 
phase and are used to guide design efforts.  The results of the design efforts at each 
design phase are the design outputs, which eventually form the specifications for the 
final device.  Verification testing is used to confirm that the Design Outputs comply with 
the specified design inputs.  Validation is the process of objectively establishing that the 
device specifications conform to the intended use and user needs.   Prototypes are 
repeatedly created, tested, and re-engineered until each design input is verified and the 
device is validated. [67, 69]  A graphical representation of this simplified outline of the 
development process is the waterfall model shown in Figure 2.2.     
 
Figure 2.2   Design Control Process. Adapted from FDA guidance document.[69] 
The FDA has determined that all intra-articular prosthetic ligament devices pose 
a significant risk and require premarket approval (PMA) prior to market entry.[70]  PMA 
approval is based upon demonstration of  safety and efficacy of the device for its 
intended use and may require clinical in addition to laboratory data.[70]  The regulatory 
pathway first requires the collection of preclinical data such as results from laboratory 
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physical, chemical, and mechanical tests as well as animal studies to be included with 
the Investigational Device Exemption (IDE) application which enables clinical 
investigation to commence with US patients.  The IDE application also requires the 
submission of an investigational plan for the clinical trial approved by an Institutional 
Review Board (IRB).   
2.6 Design inputs 
Based upon our discussions with surgeons in both the United States and France 
along with a review of the literature, we have devised a set of features defining a 
prosthetic ACL, which would provide an alternative with advantages over the currently 
available options.  The prosthetic ACL should be implantable in the currently drilled bone 
tunnel orientations, which have a demonstrated history of functionality and compatibility 
with the anatomy and physiology of the knee joint.  In general, the device should have 
three sections; the intra-articular ligament-replacing section in the center, with the 
femoral tunnel segment on one side and the tibial tunnel segment on the other.  The 
intra-articular segment of the device should be similar in size to the native ACL and 
currently accepted replacements.  Autograft and allograft size varies among patients, 
ranging from 6 to 11 mm in diameter.[71]  The ligament-replacing segment should be 
available in a range of lengths spanning 22 to 41 mm, the reported range of ACL lengths 
in adults.[72]  Each of the tunnel segments can be up to 12 mm in diameter and should 
have at least 15 mm of length within each bone tunnel.[73-74] The materials used in the 
device should be biocompatible, free of problems such as unresolved inflammation, 
immunogenicity, or cytotoxicity.   
The ligament-replacing segment mainly acts as a tensile-load bearing structure 
and should have mechanical properties similar to the natural ligament to restore ACL 
function in both the immediate and long-term.  Relevant mechanical properties include 
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tensile stiffness, ultimate strength, and ultimate strain which should be within the range 
of the native ACL and the currently used autografts and allografts.  Due to the periodic 
crimp pattern of the collagen fibrils embedded in the ground substance, the native ACL 
exhibits a multiphase stiffness profile consisting of a lower stiffness toe region at low 
levels of strain and a greater linear stiffness beyond that.[4]  The presence of a toe 
region reduces stresses at small strains, and may help prevent fatigue and creep 
damage.[75-77]  The toe region is reported to be present over the first 1 to 3 mm of 
extension, or anywhere from 2-15% strain.[78-82]  Beyond the toe, the linear stiffness of 
the ACL has been measured between 182 N/mm and 242 N/mm in young donors and as 
low as 124 N/mm in older donors.[79, 82] Autografts and allografts are several times as 
stiff as the native ligament.  The stiffness of hamstring grafts, for instance, can be as 
high as 1000 N/mm, which has not been reported to significantly diminish 
functionality.[83]  The ultimate load and strain values should not be less than their native 
counterparts and preferably greater to provide a safety factor to minimize the risk of re-
rupture.  The ultimate load of the ACL from young donors has been measured from 1730 
N to 2160 N and the ultimate elongation from 6 to 10 mm, or approximately 12-30% 
strain.[79-80, 82] 
In the native ACL, the collagen fascicles, aligned along the ligament axis, resist 
tensile but not compressive loading which results in a relatively low resistance to 
bending, folding under its own weight when held from the bottom.[6]  The ligament 
replacement should be designed to sustain repeated bending up to an angle of 80° to 
90°.[24]  According to the bending formula, EI=MR, the bending stiffness(EI) is the 
product of the Young’s modulus(E) and the second moment of area of the cross-
section(I) which is equal to the product of the bending moment(M) and the radius of 
curvature(R).  Specifying that the device should be able to bend up to 90° over the intra-
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articular length of the prosthetic while keeping the bending moment below 10 N mm, 
selected to limit transverse forces on the bones to a small value of less than 0.5 N, the 
bending stiffness should not exceed 200 N mm2.  The value of 0.5 N was selected as it 
has been previously used as an allowable tolerance in multiple kinematic studies using 
robotic/universal force moment sensor testing systems.[84-85]   
In addition to having the correct material properties at the time of implantation, 
the ACL should remain mechanically stable after long-term exposure to cyclic loading 
under in vivo conditions.  The device should be engineered with a sufficiently long 
service life such that the benefits of replacement outweigh the costs.  In the best case, 
the device would provide function for the remaining lifetime of the patient; however, we 
suspect that if the device could restore function, even for as little as several years, and 
be easily removed without any complications, it may satisfy demand for a sizeable 
segment of the market.  Active individuals take an average of 6,540 steps per day, or 
3,270 per leg.[86]   Therefore, the device will undergo approximately 1 million cycles per 
year of in vivo use with tensile loading to 450 N and bending at angles up to 90°. Over its 
service life, the device should retain functional stiffness, strength, and length, resisting 
fatigue from tensile loading and bending, damage from abrasion, and permanent 
elongation.[70]  Furthermore, any wear particulate generated from device abrasion 
should not cause adverse biological effects such as immunogenic particulation, 
inflammation, synovitis, and effusion as have been observed with previous prosthetic 
ligaments.[44] 
Each of the tunnel segments should include or be designed to accommodate 
some type of initial fixator to secure the device within the bone tunnel at the time of 
installation.  The maximum pull-out force for the fixation will need to exceed 450 N, the 
maximum force incurred over the course of rehabilitation.[78, 87]   Initial fixations 
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currently used with autografts and allografts are not completely rigid, but rather have a 
stiffness averaging between 40 N/mm and 60 N/mm.[39, 73, 87-89]  If the device is to be 
secured with a suspensory-type fixation only, the stiffness and shape of the device 
tunnel segment should be such that tunnel motion and widening are not detrimental to 
function.[90]  These effects are generally reduced when an aperture fixation is used, but 
the current literature has not yet correlated this to improved clinical results.[90-91] 
The tunnel segments should possess physical and chemical properties permitting 
strong long-term incorporation with the bone.  Past devices have varied greatly in terms 
of biologic response and anchorage within the bone tunnel due to differences in material 
and geometrical design.[92-95]  The Gore-Tex and the knitted aspect of the Stryker 
Dacron prostheses were able to provide strong long-term attachment, supporting 
infiltration by trabecular bone, intimately surrounded the individual fibers of the device, 
providing a large surface area for direct contact between the bone and prosthetic.[92-94] 
Other devices, such as the polypropylene LAD and the Leeds Keio ligament, had more 
fibrous connective tissue in the intra-osseous segment and less direct bony contact 
resulting in inferior pull out strength.[92, 94]  Studies on medical implant 
osseointegration and in the area of bone engineering have indicated some requirements 
for bony ingrowth and incorporation.[96-97]  The strength and stiffness of the tunnel 
segments should be substantial enough to support loading in vivo while not being so stiff 
as to produce stress shielding and resorption of bone near the implant.[96-98]  The 
tunnel segments should have structural and surface properties which permit bony 
ingrowth and direct apposition of the implant and the bone, allowing transfer of loads 
across the interface.  The device should also have interconnected porosity to allow cell 
migration, tissue growth, and vascularization within the tunnel segments.  Porosity of 
bone engineering scaffolds can be up to 90% by volume and the optimal pore diameter 
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for bony ingrowth is reported to be 100-350 microns.[96-97]  Hydrophilic materials allow 
diffusion of nutrients into the device providing an advantage over hydrophobic materials, 
the presence of which can prevent healthy tissue growth.[96]   
A comprehensive chart of design inputs is shown in Table 2.1. 
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Table 2.1   The Design Inputs for a next generation prosthetic ACL along with 
associated verification and validation tests. 
 Design Input Requirement Verification Test Ref. 
1 Biocompatibility Biocompatible according to 
ISO 10993 standards for 
long-term implant devices in 
direct contact with 
tissue/bone 




clinical usage history 
of materials used  
[70, 99] 
2 Stiffness 175-1000 N/mm Uniaxial tensile test [78-79, 
82, 100-
101] 
3 Ultimate Load >1730 N Uniaxial tensile test [78, 100-
101] 
4 Toe-Linear Region 
Transition Strain 
2-15% Uniaxial tensile test [78-82] 
5 Ultimate Strain >12% Uniaxial tensile test [78-82] 
6 Flexibility Transverse force<0.5 N when 
bent to 90° over intra-articular 
length  
(or Bending Modulus< 200 N 
mm2) 
Bending test  
7 Dimensions Length = 60-100 mm 
(incl. ≥15 mm in each tunnel) 
Diameter ≤10 mm 
Ruler [4, 73-74, 
102] 
8 Fatigue Functional stiffness and 
ultimate load maintained for 
>1 Million load cycles from 0 
N to 450 N 
Fatigue testing  [70] 
9 Permanent 
elongation 
<20% elongation after 1 
Million cycles from 0 N to 450 
N 
Measurement of 
length over course of 
fatigue testing after 
preconditioning 
[70] 
10 Bending Fatigue Functional stiffness and 
ultimate load maintained for 
>1M load cycles from 0° to 
80° bending 
Bending fatigue test [70] 
11 Abrasion 1) Does not lead to damage 
and loss of mechanical 
integrity 
2) Size and concentration of 
particulate matter does 
not cause problematic 
immune response in vivo 
Ex vivo mechanical 




12 Prosthetic to bone 
attachment 
strength (from 
fixation device or 
osseointegration) 
>450 N ultimate strength and 
>40 N/mm stiffness at the 
time of installation and 
maintained 1 year in vivo 
Uniaxial tensile test on 
cadaver knee (initial) 




13 Human factors Device can be installed by 
surgeons 
User validation test on 
knee model or 





2.7 Design considerations  
A prosthetic is more likely to be adopted if its method of installation is familiar to 
the surgeon; therefore, it should be similar to a biological graft in that it comprises an 
intra-articular section which replaces the ligament between sections to be secured within 
the femoral and tibial tunnels with some mechanism for initial fixation.  The device may 
be produced over a range of lengths and diameters to accommodate variation among 
patient knee sizes.  The selection of materials used to compose the device should be 
guided by the design input requirements for adequate biocompatibility, elasticity, ultimate 
strength, and durability or degradability depending upon whether it is to be a frank 
replacement or a scaffold for tissue engineering.  Synthetic or biological polymers and 
metals might be explored for the application of ligament replacement as many of these 
materials have adequate tensile strength and good biocompatibility.  Hydrogels may also 
be explored as they are hydrophilic and have the ability to absorb water like the native 
ligament.  Ceramics, though mechanically dissimilar to the ligament, may be included to 
provide benefits in terms of bioactivity and osteoinduction.[105]  Composite structures 
may enable designers provide advantageous features of several different material types 
in one device. 
The ligament-replacing segment should reproduce the nonlinear tensile response 
of the native ligament, which is a result of the biochemical composition and structural 
organization of the tissue.  Taking a biomimetic approach, such features of the native 
ligament can be incorporated into the design of the replacement to provide analogous 
functional characteristics. As with the native ligament, ropes are composed of many 
fibers arranged in a regular periodic structure, and can be used to reproduce the non-
linear mechanical response of the repeating crimped pattern of the native collagen.[60, 
106]  Rope structures are also, like the ligament, highly anisotropic and able to sustain 
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high tensile loads relative to their low flexural rigidity.  Common types of rope structures 
include those formed by parallel alignment, twisting, braiding, knitting, weaving, or some 
combination thereof.  Each of these structures differ with respect to how and to what 
degree the constituent individual filaments interact with each other which, in turn, affects 
the mechanical response.[62]  These interactions can be extremely complex involving 
multiple thousands of fibers; however, simplified analytical models of the different 
structures can be used to describe and predict behavior based upon rope design 
parameters.[107-110]   
The mechanical properties of rope structures can also be modified by altering 
pattern-specific geometrical and dimensional assembly parameters such as hierarchical 
arrangement, pitch angle, period length, and so on.[60]  Several different types of textile 
structures can be evaluated and compared first to determine the general effect of the 
pattern on the static and dynamic mechanical behavior, by comparing strength, stiffness, 
nonlinearity, as well as resistance to fatigue and permanent elongation.  Once a pattern 
type is selected as the most likely to be able to be adjusted to fit the native ACL stress-
strain relation, the pattern-specific parameters can be studied.  Sensitivity analyses can 
be used to identify the critical rope design parameters and indicate how these 
parameters might be adjusted to create a design that satisfies all the design inputs. 
One of the advantages of a prosthetic ACL over the biological grafts is that it 
enables greater overall control of the design and production, without the limitations 
imposed by having to adapt to the harvested tissue.  Sections of the device may be 
optimized independently based upon their particular combination of functional demands.  
The tunnel sections may be designed to provide a physical and chemical environment 
which can accommodate adequate cellular adhesion, proliferation, and differentiation, 
factors which determine the overall ability to promote and direct osseointegration.[111]  
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Relevant design parameters that affect osseointegration of implants include materials, 
structure, porosity, surface characteristics, biochemical properties, mechanical behavior, 
and initial fixation.  Potential to support bony ingrowth has been demonstrated with a 
wide range of materials including metals, ceramics, polymers.[111]  Morphologically, 
porous and interconnected network structures with greater surface area are superior to 
solid structures with smooth surfaces for both bony ingrowth and integration.[111]  
Increasing porosity can enhance transport of oxygen, nutrients, growth factors, and 
waste while providing greater space for ingrowth of the new bone, however, it should be 
noted that increases in porosity come at the expense of mechanical strength and 
stiffness.  The optimum pore size for bone regeneration is between 200 and 400 um, 
which is large enough to prevent cellular occlusion of the pores, but not so large that 
cellular adhesion and proliferation are compromised.[111]  Bioactive agents, such as 
calcium phosphates, growth factors, and adhesion-promoting oligopeptides have also 
been shown to increase the rate of integration and may be included.[105] The 
mechanical stimuli to which the cells are exposed determines the type of ECM 
produced.[111]  Therefore, some effort should be placed on designing the tunnel 
segments with adequate mechanics matching and a secure initial fixation. 
2.8 Proposed solution 
Polyvinyl alcohol (PVA), a hydrophilic polymer, would have several 
advantageous features as a prospective material for ACL replacement. PVA in the 
hydrogel form of Salubria® (Salumedica, Atlanta, GA) has demonstrated good 
biocompatibility and functional capacity in several soft-tissue replacement applications 
including a nerve sheath, replacement of knee articular cartilage, heart valves, and 
spinal disks, which, like a prosthetic ACL undergo repeated loading and frictional 
conditions in vivo.[112] Stronger materials such as ultrahigh molecular weight 
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polyethylene (UHMWPE) may be used to supplement the PVA to provide an increase in 
the ultimate tensile load or improve creep or fatigue resistance.  UHMWPE has 
demonstrated good biocompatibility and success in hip, knee, ankle, and elbow 
replacements and surgical sutures for humans and in ligament replacements for 
dogs.[113-114] 
The tunnel segments of the device may be designed as a braided tubular 
structure providing multiple features suited the demands of short and long term fixation.  
The fibrous interlocking arrangement of the braid provides interstices akin to porosity 
thereby allowing ingrowth around the fibers and into the device. The tubular shape can 
be made such that, when installed in the knee, the outer surface of the device is in 
contact with the inside bone surface around the entire circumference of the tunnel 
maximizing the active surface area for bone to graft attachment.  Full circumferential 
graft to tunnel contact is possible with the current graft options if a suspensory type 
fixation is used, but other fixations such as screws are inserted between the graft and 
the bone tunnel wall reducing the surface area for contact.  By adopting a tubular shape 
for the tunnel segment a screw may be placed in the open space and used to compress 
the device against the bone tunnel walls from the inside.  The addition of loops adjacent 
to the extra-articular ends of the tubular sections allows for compatibility with suspensory 
fixations such as buttons, screws, or staples, which may be used in conjunction with or 
in lieu of fixation at the aperture.  Hydrogels swell as they absorb water, and within the 
bone tunnels may help reduce tunnel motion by increasing the pressure and tightness of 
the fit against the bone tunnel wall.  Finally, bioactive substances such as calcium 
phosphates, growth factors, or adhesive peptide sequences may be applied to the 




2.9 Risk analysis 
Risk analysis, the structured process of identifying and evaluating potential 
problems that may result from usage of the device, is required during the medical device 
design process for FDA and ISO compliance.[67, 115]  Risk analysis tools include fault 
tree analysis (FTA) and failure mode effects analysis (FMEA).  Risk analysis helps 
product developers to identify potential deficiencies during the design and manufacturing 
process prior to distribution to avoid costly recalls or product liability issues. 
FTA begins by first identifying all the possible failure effects and then listing the 
potential ways of creating each hazard so they can be designed out.  Failure modes can 
be diagramed on a fault tree connected by logical operators such as “and” and “or” gates 
and traced back to the contributing basic root causes.  Countermeasures can then be 
applied to avert or mitigate the identified hazards thereby reducing risk.  An example risk 
analysis for a prosthetic ACL is presented in Figure 2.3.  The identified possible failure 
modes include unsatisfactory knee function and immunological rejection that can result 
from design inadequacies or user errors.  Selection of appropriate materials and 
structural design should be ensured with thorough verification testing of comprehensive 
design inputs prior to release of the device.  Improper installation and patient selection 
originate from the user and should be examined with validation tests.  Training, labeling, 
product literature, and indications for use can be used to reduce the level of risk arising 




Figure 2.3   A fault tree diagram for a prosthetic ACL.  Failure modes are traced 
back to root causes which can be countered as a part of the design process. 
FMEA is a manufacturing tool to assess reliability by analyzing potential failure 
modes of the device, beginning by identifying potential defects, their effects on safety or 
performance, and possible solutions. It is often extended to include criticality analysis 
wherein each hazard is assessed with respect to severity of consequences, probability 
of occurrence, and probability that it will escape detection before reaching the customer.  
These factors can then be combined to determine priority ranking so that the hazards 
which present the greatest danger can be the first to be addressed with corrective 
actions.  One method is to assign numerical ratings to severity, probability, and detection 
and computing the product to yield a Risk Priority Number (RPN); however, other 
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methods to determine rank have been proposed and may be superior depending on the 
application.[116]  
2.10 Verification testing 
Design Verification is the process of acquiring objective evidence confirming that 
the design inputs are met. [67]  Uniaxial tensile testing may be used to verify most of the 
mechanical design inputs.  Samples can be pulled to failure to test for ultimate strength 
and ultimate strain or to subfailure loads to test for stiffness focusing on the functional 
range in vivo.  Preconditioning may be necessary to assess viscoelastic effects.  Testing 
should be performed with the samples submerged in normal physiological fluid 
maintained at 37°C unless it is demonstrated that the structural and material properties 
are not sensitive to these factors.[70]  Testing should be performed at several 
physiologically relevant strain rates to detect any effects on the stress-strain behavior.  
Mechanical testing of ligaments at strain rates from 0.1%/s up to 100%/s, spanning the 
range from very slow to very fast motion, has shown that the strain rate does not 
significantly affect linear stiffness but does affect the strain range of toe region, which 
reduces as the strain rate increases.[79, 82, 117]  Adequate flexibility can be assessed 
by measuring the resultant transverse force directly when the device is bent to 90° over 
the intra-articular length.   
The functionality of the prosthetic ligament may be compromised by the effects of 
cyclic loading such as permanent elongation and fatigue.  To test for such effects, a 
periodic load-cycle curve similar to the native ACL such as that described by Shelburne 
et al.[118] may be imposed over a physiologically relevant force range to simulate the in 
vivo condition.  Simpler sinusoidal or triangular waveforms may also be used if any 
effects of differences in strain rate and strain energy density can be accounted for and it 
can be demonstrated that the data acquired remains meaningful and relevant to the in 
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vivo response.  Over the course of cyclic loading, the stress-strain curves should be 
measured and recorded, from which the change in stiffness and any progression of 
permanent elongation can be determined as a function of the number of cycles.  For the 
design to be acceptable, the device should be intact with stiffness and length remaining 
within functional limits after exposure to the number of cycles expected to occur over its 
specified service life. 
Clinical evidence indicates that cyclic exposure to bending and abrasion are 
modes of degeneration potentially contributing to device failure.  Therefore, in addition to 
uniaxial tensile static and fatigue testing, cyclic bending and abrasion responses may be 
used for verification testing of prosthetic knee ligament devices.[70]   Ex vivo mechanical 
tests to evaluate bending fatigue would involve subjecting the prosthetic to repeated 
bending and loading, simulating the in vivo condition near the intra-articular bone tunnel 
exits with regards to graft bending angle combined with tensile loading.  The fixations 
may also be included in these tests.[70]  As with the tensile fatigue tests, the device 
should maintain functional length and stiffness over the duration of the service life.  In 
vitro abrasion testing may be included as a part of the bending fatigue test, utilizing 
cadaver bone or appropriately graded abrasive material to simulate the sections of bone 
against which the device will rub.[70]   The histological and pathological effects of the 
abraded particulate matter should be evaluated in vivo with particle migration and animal 
studies.[70] 
Testing should be conducted to ensure that the functional demands of the bone-
to-ligament interface are sufficient through the rehabilitation period and in the long-term 
thereafter.  Ultimate tensile (pull-out) force testing of the initial fixation can be carried out 
on devices secured in tunnels drilled in cadaver knees.  Functional demands of the initial 
fixation in terms of strength are lower, as early activity will be limited to low loading 
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during rehabilitation.  The long-term demands for strength increase with the level of 
activity, generally requiring augmentation with bony incorporation.   
Biocompatibility testing on representative products made under Good 
Manufacturing Practices is required to determine if and to what degree the implant might 
cause any adverse toxicological effects.  Standards are available for pyrogenicity testing, 
hemolytic potential, acute toxicity, intracutaneous irritation, cytotoxicity, and genotoxicity 
testing to acquire hazard identification information at the pre-clinical stage.[70]   
The FDA may also require pathological or mechanical studies of devices 
implanted in animals.  The FDA Guidance Document notes that studies on sheep, goats, 
and dogs have been previously used and may be appropriate.[70]  Animal tests can be 
used to assess the in vivo histological and immunological reaction, material degradation, 
abrasion, damage, and wear migration, as well as changes in mechanical properties, 
fixation strength, and longer term bone-to-ligament attachment strength over the course 
of biological integration in vivo.[70] 
Clinical trials to demonstrate safety should report evidence of device rupture, 
joint swelling, tenderness, effusions, synovitis, as well as local or systemic infection. [70]  
Efficacy and function can be directly assessed using the anterior drawer test, Lachman 
test, and pivot shift test and the device itself can be examined using MRI.  Clinical 
outcome can be measured in terms of the Lysholm knee scoring scale, Tegner activity 
scores, or IKDC scores.[70]  
2.11 Discussion 
 A prosthetic ACL would solve many problems associated with the existing 
options for ACL replacement, such as donor site morbidity and the necessity of the 
harvest operation in the case of autografts as well as lack of availability and disease 
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transmission risk associated with allografts. Synthetic ACL prostheses have been 
withdrawn from the US market since the early 1990s due to lack of biocompatibility and 
recurring mechanical failures; however, new advances in biomaterials, surgical 
techniques, biomechanics, and tissue engineering provide an opportunity to design a 
new generation of prosthetic ACL replacements with the goal of improving 
biocompatibility, mechanical behavior, fixation, and bony integration.  The development 
of prosthetic ACL device, installable with current surgical techniques, with good 
biocompatibility, mechanical behavior similar to the native ACL, and the ability to provide 
function over millions of cycles would be a significant advance in the field of knee 
surgery.  The availability of an off-the-shelf alternative to autografts and allografts would 
reduce operation times and costs, accelerate recovery, and improve outcomes, 
providing clear advantages for both patients and surgeons. 
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CHAPTER 3   Mechanical Evaluation of Materials and Rope Structures for an 
Anterior Cruciate Ligament Prosthesis 
3.1 Introduction 
The ACL is a tensile load bearing structure functioning as a restraint to excessive 
anterior translation of the tibia relative to the femur, maintaining proper knee orientation 
and stability.[1-2]  Tearing or rupture of the anterior cruciate ligament (ACL) is a 
relatively common sports-related injury with up to 100,000 cases each year in the United 
States.[3] Due to the poor blood supply of the ACL in the adult, it does not heal on its 
own nor respond well to primary repair; therefore, reconstruction with an autograft or 
allograft is the currently prescribed method of treatment.[4]    
The usage of autografts is associated with good results; however, drawbacks 
such as residual donor site morbidity, longer recovery times, and the requirement of the 
additional harvest operation would make a prosthetic with off-the-shelf availability an 
attractive alternative for many surgeons and patients.[5]  Beginning in the 1970s, a 
series of prosthetics were developed from a wide range of polymeric materials; however, 
due to high rates of mechanical failure and immunogenic particulation, the field has 
turned away from these types of devices.[6]  As surgical techniques and tools have since 
improved and a wider range of novel biomaterials have become available, the question 
of whether a functional prosthetic can be developed is worth exploring again. 
To adequately restore function, a prosthetic device should possess mechanical 
properties within the range of the native ACL or the currently accepted replacements.  
As a function of the composition and orientation of the tissue, the native ligament 
exhibits a nonlinear elastic response in which at low levels of strain, there is a low 
stiffness toe regime, and at greater levels of strain, a higher stiffness linear regime.[7]  
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The strength and linear stiffness derive from collagen in the form of fibrous bands 
arranged axially in parallel.  A periodic crimped or wavy pattern in the collagen accounts 
for the observed toe region.[7]  The collagen is embedded in a hydrophilic ground 
substance consisting of proteoglycans, elastin, and water.[7]  The mechanical design 
inputs for the ligament-replacing section of a prosthetic ACL replacement are outlined in 
Table 3.1.   
Table 3.1  Mechanical design inputs for a prosthetic ACL. 
Design Input Value Verification Test Ref. 
Stiffness 35-400 N/% Uniaxial tensile test [8-11] 
Ultimate Load >1730 N Uniaxial tensile test [8-9, 11-12] 
Toe-Linear Region 
Transition Strain 
2-15% Uniaxial tensile test [4, 9, 13-16] 
Ultimate Strain >12% Uniaxial tensile test [4, 9, 13-16] 
Fatigue Functional stiffness and 
ultimate load maintained 
for >1M load cycles from 
0N to 450 N 




elongation after 1M 
cycles from 0N to 450N 
Measurement of 
length during of 
fatigue testing 
[17] 





Figure 3.1   Force vs. strain relationship for the native ligament shown alongside 
patellar tendon graft and double-looped hamstring graft.[2, 4, 9, 13, 15, 19] 
3.2 Methods 
3.2.1 Materials selection 
Polyvinyl alcohol (PVA) is a promising biomaterial with excellent biocompatibility 
currently showing potential in several soft-tissue replacement applications such as knee 
cartilage and vein valve repair.[20-21]  PVA is hydrophilic, forming a hydrogel when in 
contact with water.  It can also be manufactured in a fibrous or filamentous format.  We 
hypothesize that PVA arranged in a periodic rope pattern can provide an acceptable 
mechanical response for ACL replacement.  A high-strength material, such as ultrahigh 
molecular weight polyethylene (UHMWPE) may also be added to provide additional 
support and a safety factor in terms of ultimate load.  UHMWPE has been implanted for 
many years as a component of hip, spine, and knee replacements for humans and in 


























3.2.2 Design considerations and process overview 
The nonlinear tensile behavior of the native ligament, derived from the periodic 
structure of the collagen fibers, is not likely to be reproduced by a solid bulk material or 
straight fibers arranged in parallel.  Biomimetic principles suggest that rope structures, 
being periodic, wavy, and fibrous, may be better suited for a ligament replacement.  The 
approach taken in this investigation is as follows.  In Study 1, PVA and UHMWPE were 
mechanically assessed as prospective materials for ACL replacement with the objective 
of determining the quantities of each material required to provide adequate strength and 
stiffness while remaining within dimensional constraints.  Then, in Study 2, several basic 
types of structures were compared experimentally to determine the effect of rope pattern 
on tensile behavior, and from that select the pattern with the most ligament-like 
response.  Next, in Study 3, pattern-specific geometrical parameters were analytically 
and experimentally studied to converge upon a final design to adequately match the 
static response.  Finally, in Study 4, the long-term behavior of the final design is tested 
by applying repeated loading simulating the in vivo condition and observing the 
progression of fatigue and elongation. 
3.2.3 Rope analysis 
Filaments are arranged in rope structures to force them to act as a single unit 
and increase tensile strength.  Methods to organize filamentous materials into rope 
structures include twisting, braiding, knitting, and weaving.  The mechanical response of 
each of these structures is dependent upon the material composition as well as 
structure-specific geometrical assembly parameters.  Furthermore, hierarchical 
arrangements can be imposed with different patterns at each level or layer.  A brief 




3.2.3.1 Twisted structures 
Gegauff was the first to analyze twisted yarn structures and derive a simple 
relationship between the twisting angle and the tensile modulus.[24]  In this model, the 
yarn is idealized as a series of concentric cylindrical layers each consisting of helically 
wound filaments.  Focusing on one layer at a radial position, r, let the helix angle at that 
layer be denoted by θ and the length along the yarn axis for one complete turn be 
denoted by h.  The length along the filament axis for one complete turn is denoted by l.  
δh and δl represent elongations along the yarn axis and filament axis respectively. 
 
Figure 3.2   Ideal geometry of a twisted yarn (left) and flattened projection of one 
filament over one helical turn (right).[25] 
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The strain in the yarn, εy, and the strain in each filament in the layer, εf, are 
defined as follows: 
 = ℎ ℎ⁄ , 
 =  ⁄ . 
Furthermore, we can see that, 
ℎ =  cos , 
and 
ℎ ≈ / cos , 
assuming the change in θ is small. 
Therefore, by substitution, the relationship between yarn and filament strain is, 
 =  cos . 
If Fy is the component of force in the direction of the yarn axis in each filament in 
the layer, the force in the filament along the filament axis is Ff = Fy/cos θ.  Additionally, 
the area of the cross-section perpendicular to the axis of the filament, Af, can be 
expressed as a function of the area of the cross-section perpendicular to the yarn axis, 
Ay, as, Af = Ay cos θ.  The stress in each filament of each layer, σf = Ff/Af, can therefore 
also be calculated in terms of the equivalent stress in the layer, σy = Fy/Ay.  At each layer 
the stress in the filaments can be expressed as,  
 =  /cos . 
And since the modulus of the rope is Ey = σy / εy , and the modulus of the filament 
is Ef = σf / εf ,at each layer, they can be related for each layer as, 
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 =  cos . 
Now, looking at the whole rope as a series of concentric layers, the average 
value of cos4θ is cos2α where α is the helix angle for the outermost layer.  Therefore, 
 =  cos . 
Subsequent experimental studies have shown that the reduction in modulus 
resulting from the twisting of filaments into yarns is greater than this simple model 
predicts and more complicated models have been developed.  White et al.[26] derive the 
relationship as, 
 =   +  +  ln  ⁄  , 
where T = cos2α. 
Another model derived by Rao et al.[25] takes into account the shear modulus of 
the filament yielding, 
 =  !"# + "#$#% &'($ ) ln #"# * , 
where d is the ratio of the longitudinal modulus to the shear modulus. 
It is important to note that these models neglect any radial contraction of the rope 
as it is strained in the axial direction.  
3.2.3.2 4-strand square braided structures 
Braiding is broadly defined as interweaving three or more lengths of material into 
a diagonal overlapping pattern.  A square braid is composed of four subunits, arranged 
in a way such that one pair zigzags across itself in one plane and the other pair does the 
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same in the perpendicular plane.  A schematic of the centerline of the structure is shown 
below. 
  
Figure 3.3   Idealized geometry of a 4-strand square braid (left) and magnification 
of one square braid unit cell (right). 
Approximating a unit cell as a right triangle, the stiffness of the overall structure 
can be predicted as a function of the material properties of the constituents.   The angle 
between the component and the braid axis is denoted as φ, the axial length as h, and 
the component length as l.  With an analysis parallel to the single layer of the twisted 
rope described above, it can be shown that 
 = + cos, , 
where Ey is the modulus of the yarn, and Ec is the modulus of the component.  This 
relationship can be used directly to estimate yarn modulus.  As in the twisted models 
described above, radial contraction is neglected. 
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3.2.3.3 Hollow braided structures 
Another type of braided structure is the circular or hollow braid which forms an 
open cylinder with a diamond lattice pattern.  The mechanics of these types of structures 
is described by Hopper and Grant.[27]  In the simple case, in which there is nothing 
inside of the circular braid, there are two modes of configuration, unjammed and 
jammed, which determine the mechanical response.  As axial loads are first applied to 
these braids, the diamond extends along the axial direction while simultaneously 
contracting in the circumferential direction.  Jamming occurs when, upon axial 
elongation, the space between each of the components in the circumferential direction 
collapses to zero.  In the unjammed state, as axial strain is imposed, there is no strain 
incurred in each of the braid components, but rather the axial strain is only a result of the 
deformation of the diamond lattice.  The resistance to extension is due only to negligible 
frictional effects and not the properties of the components.  In the jammed state, 
circumferential contraction is restricted, and therefore as axial strain increases, strain is 
also incurred in the components. 
The locking angle, θL, can be calculated from the following relationship, 
sin2/ = 012 sin3, 
where w is the width of each component, X0 is the initial lateral dimension of the 
diamond lattice, and θ0 is the initial angle between the braid axis and the components. 
In the unjammed state, the axial force generated with axial strain is very low as 
there is very little resistance to deformation of the diamond lattice.  Conversely, upon 
transition to the jammed state, the stiffness rapidly increases as axial strain is resisted 
by tension and strain in each of the braid components.  The total axial tension in the 
braid can be determined as a function of the braid and yarn properties as 
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4 = 5+678 cos /, 
where N is the number of components, and Tb and Tcomp are the tension in the braid and 
each component respectively.  Tcomp can be determined as a function of the strain in 
each component, εcomp, given the material stress-strain relation.  The component strain 
can be calculated from the braid strain, εb, as 
+678 = 4 cos . 
The addition of an elastic core in the center of the hollow braid is slightly more 
complex as there are additional modes.  In the first mode, the hollow aspect is 
unjammed and is not in contact with the central core.  As extension occurs in Mode I, the 
diamond lattice of the hollow aspect deforms without strain being incurred in the 
components.  The core, however, does bear load and strain, while also contracting 
laterally due to the Poisson’s effect.  The Mode I force is only dependent upon the core 
and can be expressed as, 
9 = :+;<3 ,   
where kc is the stiffness of the core, εz is the axial strain, and L0 is the initial length.  
Mode I type behavior occurs under the condition that the inner radius of the hollow 
aspect is greater than the radius of the core.  This relationship can be expressed as, 
=1 − @A"@A$&'($ B2 − C > E+31 − F;  
where θ0 is the initial helix angle, t and rc0 are the thickness and initial core radius of the 
hollow aspect relative to the width of the diamond lattice respectively, and ν is the 
Poisson’s ratio of the core. 
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In Mode II, the hollow braid remains unjammed, but has come into contact with 
the elastic core.  The resistance of the elastic core to compression results in tension in 
each of the hollow braid components.  Therefore, the force along the braid axis of the 
construct consists of contributions from both the core and hollow aspect.  In this mode, 
the inward and outward forces between the core and hollow aspect must be balanced to 
solve for the radius and helix angle.  To do this we set the inner braid radius equal to the 
core radius obtaining, 
GH"@IJ$KL($ B2 − "@A$&'($ B2 − C = E+31 − M , 
where εy is the hollow braid component strain and εr is the core radial strain, 
M = − "NNOPMP2$ KL($ BQ@IRMS$ TUKB − F; ,  
where ϕc is the core packing factor, ζ is a non-linear correction factor, and rb  is the non-
dimensional braid radius.  Additionally, 
V = OPWP/2XOIWI/I2 , 
where ϕy is the braid component packing factor, ky is the component axial stiffness, and 
Ly0 is the component initial length. 
In Mode III, the hollow aspect of the braid becomes jammed while remaining in 
contact with core.  When the core laterally constricts to the point it is no longer in contact 
with in jammed hollow aspect, this is Mode IV.  In each of these modes, the angle can 
be calculated as, 
/ = sin 0 &'(B2"@A , 
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where w is the non-dimensional width of each hollow aspect component.  The non-
dimensional braid radius can be calculated as, 
E4 = GY$Z[$\]^_2`abA  $
 . 
In general, the yarn strain is 
 = TUKB2TUKB 1 + ; − 1 . 
Furthermore, the total axial force can be calculated as, 
 = 5c:<3 de cos  + V !N@A"N@f"NN *g	. 
The complete derivation of these relationships for hollow braided ropes is found in the 
paper by Hopper and Grant.[27] 
3.2.4 Rope preparation 
Filaments of PVA were fine and difficult to manage individually. Therefore, fifteen 
monofilaments of PVA were twisted together to form a thread and fifteen of these 
threads were again twisted together to make one cord.  Each cord was approximately 
two millimeters in diameter.  UHMWPE threads were 4-component braided structures 
approximately half a millimeter in diameter.  Each UHMWPE thread braid component 
consisted of many very fine filaments in parallel.   
For Study 1, the PVA cord and UHMWPE thread were first tested on their own to 
determine how much of each material would be needed to provide stiffness and strength 
within the range of the native ACL or currently accepted grafts while remaining within 
size constraints.  Subsequently, twisted ropes consisting of 16 PVA cords were tested 
and compared to the same supplemented with 12 UHMWPE threads to determine if 
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there were any significant advantages with the addition of the UHMWPE.  The 16 PVA 
twisted structures with or without the UHMWPE were approximately 8 mm in diameter, 
an appropriate size for an ACL replacing device.[2, 18, 28] 
To examine the effect of rope pattern on the static tensile behavior of the device 
in Study 2, samples were created with the following pattern types: (1) twisted, (2) 4-
strand square braided, and (3) hollow braided with elastic core.  Each of the types 
contained a controlled quantity of 16 PVA cords and 12 UHMWPE threads, such that 
rope pattern would be the only variation.  For the twisted samples the UHMWPE threads 
were aligned in parallel and utilized as a single unit and along with each of the PVA 
cords were twisted around the longitudinal axis of the sample.  For the 4-strand square 
braided samples, three of the strands were parallel bundles each consisting of 4 PVA 
cords and the fourth strand was a bundle of 4 PVA cords together with 12 UHMWPE 
threads.  Finally for the hollow braid, 16 PVA cords were aligned in parallel forming the 
elastic core and surrounded with tubular diamond braid of 12 UHMWPE threads.   
Study 3 focused on the hollow braid design parameters.  To study the effect of 
core size on the mechanical response of hollow braided structures, samples with 8, 12, 
and 16 PVA cords in the core surrounded by 12 UHMWPE threads.  The respective 
diameters of these constructs were 5.5 mm, 7 mm, and 8 mm respectively.  Then, to test 
the effect of the helix angle, samples with 16 PVA cords in the core and 12 UHMWPE 
threads in the braid were created over a range of helix angles.  The long-term 
performance evaluation, Study 4, was carried out on hollow braided structures with 8 
PVA cords as the core surrounded by 12 UHMWPE threads.   
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3.2.5 Braid computational analysis 
Using the analytical model for the hollow braid with an elastic core as described 
by Hopper and Grant,[27] a MATLAB function was written to calculate the theoretical 
force versus strain relationship as a function of PVA cord and UHMWPE thread 
quantities, mechanical properties, and braid geometrical parameters such as core 
diameter and lattice dimensions. 
3.2.6 Static tensile testing 
Samples were submerged in water at room temperature for 24 hours, then 
removed from the water and tested wet on an Instron 5966 materials testing system 
(MTS).  For pull-to-failure tests, carried out to determine ultimate strength, capstan 
fixations with a diameter of 7 cm were used to secure the samples from each end.  The 
long ends of each sample were wrapped around each capstan three times and tied to 
the frame and crossbar on the materials testing machine.  Capstans were used because 
they provided a holding force greater than the ultimate load of the samples and 
increased the likelihood that rupture occurred in the body of the sample due to the 
tensile force.  Other systems such as gripping with clamps or tying the sample around 
bars had greater amounts of slippage and were prone to cutting the samples or inducing 
abnormal stress concentrations leading to premature failure at the grip to sample 
interface.  For sub-failure tensile testing, focusing on the physiologically relevant force 
range for both normal and strenuous activity up to 700 N, large wedge clamps were 
used as they adequately gripped the samples from each end without causing slippage 
and damage.[9, 29] 
Samples were pre-stretched for 20 cycles between 0 and 700 N before being 
pulled for testing at a rate of 2% per second, corresponding to a medium to slower 
motion in vivo.[30-31]  The rate was fast enough to ensure negligible drying over the 
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duration of the test.  To avoid distortion of results introduced by the irregularities of grips 
and clamping system, strain was independently measured and calculated from a video 
recording of the motion of black markers on the midsubstance of the sample and 
subsequently synchronized with force measurement data from the MTS.  The frame 
grabbing system consisted of an AVT Pike camera placed approximately 1.5 meters 
away from the test sample with a data acquisition rate of 2 images per second.  From 
the video, recorded to a PC, each frame in sequence was then analyzed with a custom 
marker pixel tracking software application to determine the strain.  The resolution of the 
system was approximately 100 µm, accurate to 0.2% strain. For each sample type and 
static test a sample size of n≥5 was used. 
3.2.7 Long-term mechanical testing 
A custom testing system was assembled to apply long-term cyclic loading to rope 
samples.  After preloading to 500 N, the system operated in force control mode in the 
normal non-strenuous activity force range between 50 N and 450 N up to 1 million cycles 
at a frequency of 1 Hz, while constantly recording force and displacement data.[9]  The 
samples (n=4) were clamped at each end and completely submerged within a cylindrical 
chamber filled with water at room temperature for the duration of the investigation.  
Force and displacement data was used to record the progression of fatigue and 
elongation as well as changes in the static response.  Gross observation of the sample 
was used to identify wear and damage.  Testing was extended to determine number of 




3.3.1 Study 1: Material evaluation 
Tests on single PVA cords indicate an average stiffness slightly greater than 2 
N/% and an ultimate load close to than 140 N.  Therefore, it was predicted that a 
minimum of 15 to 20 PVA cords in parallel would be required to provide the minimal 
stiffness requirement of 35 N/% if only PVA were to be used.  UHMWPE threads had a 
much greater stiffness close to 100 N/% and a greater ultimate load of 375 N despite 
having only a small fraction of cross-sectional area of the PVA.  Six UHMWPE threads 
together would be adequate to provide an ultimate load exceeding 2160 N, the average 
ultimate load of the ACL in the young adult.[13] 
 




Figure 3.5   Force versus strain relationship for one saturated PVA cord and one 
saturated UHMWPE thread. 
Twisted bundles of 16 PVA cords, which were 8 mm in diameter, similar in size to 
an average hamstring graft,[18] were found to have a stiffness close to the lower bound 
for acceptability and strength slightly inferior to the native ACL.[13]  Increasing the 
number of PVA cords to 22, the maximum allowable before exceeding our size 
constraints, provided an ultimate load equivalent to the average ACL, however did not 
provide any safety factor beyond that.  Addition of 12 UHMWPE threads twisted together 
with 16 PVA cords provided an ultimate load twice that of the native ACL without 
significantly increasing the diameter; however, this arrangement also resulted in a very 
high stiffness when the response was dominated by the UHMWPE.  The desirability of a 
safety factor for ultimate load supported the conclusion that the inclusion of 12 
UHMWPE threads would be advantageous, but raised the question of whether it would 
be possible to keep that strength while reducing stiffness closer to the level of native 
























Figure 3.6   Force versus strain relationships for a twisted bundle of 16 PVA cords, 
and the same twisted along with 12 UHMWPE threads compared with the native 
ACL and hamstring autograft.[2, 13, 19]  
The results of Study 1 demonstrated that a quantity of 15 to 22 PVA cords 
provided good stiffness for ACL replacement, however, using more than 16 PVA cords 
resulted in a diameter greater than the ideal.  Additionally, it was found that much 
greater strength would be provided with the addition of 12 UHMWPE threads, but that 
the stiffness of the UHMWPE far exceeded that of the ACL.  It was hypothesized that a 
biomimetic composite structure using PVA cords and UHMWPE threads arranged with 
some type of periodic rope pattern could result in a hybridization of the mechanical 
properties of two materials resulting in the desired ligament-like response. 
3.3.2 Study 2: Effect of rope pattern 
To evaluate how the rope pattern affects the static tensile behavior, twisted, 4-
strand square braided, and hollow braided samples were created for mechanical 
comparison, each composed of a controlled quantity of 16 PVA cords and 12 UHMWPE 



























physiologically relevant force range from 0 N to 700 N, and compared to the native ACL 
and currently used autografts.  Twisted and 4-strand square braided samples exhibited a 
very similar behavior characterized by a well-defined low stiffness PVA-dominated 
regime at low strain and a very high stiffness UHMWPE dominated regime at higher 
strains.  The transition in both of these types of patterns occurred relatively rapidly, over 
a three percent change in strain beyond which the stiffness of the UHMWPE-dominated 
regime was close to three times as stiff as the native ACL.  Alternatively, the hollow 
braided samples had a much more gradual transition from low to high stiffness spanning 
across approximately 10 percent strain before being completely dominated by the 
UHMWPE.  Notably, the stiffness over the course of the transition approached that of the 
normal young ACL. 
 




Figure 3.8   Force versus strain relationship for twisted, 4-strand square braided, 
and hollow braided specimens compared to the native ACL and hamstring 
autograft.[2, 13, 19] 
The results of Study 2 established the hollow braided structure as providing the 
most ligament-like mechanical response and led to the question of how the geometrical 
and compositional parameters of hollow braided structures could be altered to further 
diminish the contribution of the UHMWPE in the functional strain range and achieve 
stiffness nearer to that of the native ACL. 
3.3.3 Study 3: Effect of hollow braid parameters  
Proceeding with hollow braided structures, the inclusion of 12 UHMWPE threads 
was specified as that was the minimum amount capable of providing an ultimate strength 
double that of the native ACL.  Other parameters left to adjust included the number of 
PVA cords in the core and the helix angle at which the UHMWPE threads were to be laid 




























Figure 3.9   Hollow braid geometrical parameters include the helix angle (θ0), 
circumferential braid dimension (X0), longitudinal braid dimension (Y0), and core 
diameter. 
The effect of the number of PVA cords in the core was studied first.  Hollow 
braids with 12 UHMWPE threads outside and cores composed of 8, 12, and 16 PVA 
cords in parallel, with diameters of 5.5 mm, 7 mm, and 8 mm, respectively, were tested 
and compared to the native ACL over the physiologically relevant force range from 0 N 
to 700 N.  The force versus strain curve (Figure 3.10) shows that increasing the number 
of PVA cords had the effects of increasing the stiffness of the toe region in direct 
proportion to the number of PVA cords and smoothing the transition from lower to higher 
stiffness resulting in a more ligament-like stiffness overall.  These finding suggested that 
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more PVA in the core would be superior, however, increasing the number of cords 
beyond 16 would result in a diameter larger than the currently used grafts.[18]  To avoid 
any size issues, 16 PVA cords was selected as the ideal quantity for the core. 
 
Figure 3.10  Force versus strain relationships for hollow braided samples with 8, 
12, and 16 PVA cords in the core shown with the native ACL and hamstring 
autograft.[2, 13, 19] 
Next, the effect of helix angle was studied by comparing hollow braided samples 
with 16 PVA cords in the core and 12 UHMWPE threads braided around the outside at 
helix angles of 40°, 45°, 50°, and 55°.  Experimental tensile test results were compared 
to the computed analytical results and the response of the native ACL.  The 
circumferential braid dimension, X0, was determined by the size of the core and 
measured to be 2.1 mm in all tested samples.  Increasing the helix angle had the effects 
of increasing the span of the toe region and reducing the stiffness at higher levels of load 
and strain.  Experimental results in showed good agreement with the analytical 



























provided by samples with 12 UHMWPE threads braided around a core of 16 PVA cords 
with a braid helix angle between 40° and 50°.
 
Figure 3.11  Predicted and experimentally measured force versus strain 
relationship for hollow braids with 16 PVA cords in the core and helix angles of 
40°, 45°, 50°, and 55° shown with the native ACL and hamstring autograft.[2, 13, 
19] 
Table 3.2   Mechanics design inputs with verification test results 
Design Input Target Value Value attained with 16 PVA cord + 
12 UHMWPE thread hollow braid 
Stiffness 35-400 N/% 63-179 N/% 




Ultimate Strain > 12% > 31.6% 
Diameter < 10 mm 8 mm 
3.3.4 Study 4: Long-term evaluation 
 Hollow braided samples were able to withstand cyclical loading over the 
physiological force range up to 1 million cycles, the point at which testing was stopped.  
































course of loading, due to slight bedding in of the UHMWPE fibers into the PVA core.  
Slippage at the clamps made an accurate determination of permanent elongation 
difficult; however, the test revealed that the upper bound for permanent elongation after 
1 million cycles was about 10%.  Gradual progression of minor fraying and wear of the 
outer PVA core fibers was also observed, likely a result of abrasion from contact with the 
UHMWPE threads.  This damage was not detrimental to the mechanical function of the 
samples.  A separate test on a braided construct with the equivalent quantity of 
UHMWPE and 22 PVA cords was able to withstand more than 4.5 million cycles before 
rupture.  The results of Study 4 demonstrated that the long-term performance of PVA 
and UHMWPE composite ropes with the proposed hollow braided structure satisfy the 
design inputs for resistance to tensile fatigue and permanent elongation. 
 
Figure 3.12  Samples at the first cycle, after 300,000 cycles, and after 1 million 




Figure 3.13  Load versus deformation curves over the course of cyclic loading. 
Figure 3.14  Deformation from the application of 50 N and 450 N over the course of 
cyclic loading.  Deformations are calculated relative to the length at the first cycle 




Composite structures of PVA and UHMWPE possess adequate mechanical 
properties to be employed as the ligament-replacing aspect of a prosthetic ACL device 
with the desired mechanical response provided by a hollow diamond braid with 
UHMWPE threads around a core of PVA cords in parallel.  This arrangement was 
capable of producing a response between that of only PVA or UHMWPE over the 
functional force and strain ranges, demonstrating clear superiority over twisted or 4-
strand square braided structures, which had distinguishable strain ranges where the 
response was either strongly dominated by PVA or UHMWPE.  The quantity of twelve 
UHMWPE threads was selected to provide an ultimate load double that of the native 
ACL, providing a 100% safety factor to reduce risk of rupture.  It was found that 
increasing the amount of PVA in the core reduced the contribution of UHMWPE at 
higher levels of strain resulting in stiffness closer to the native ACL.  The quantity of 
sixteen PVA cords was selected for the core as it was the maximum amount that could 
be included before increasing the diameter of the device beyond that of an average 
hamstring graft.  The final parameter to be defined was the helix angle of UHMWPE 
threads in the braid, found to closely reproduce the tensile response of the native ACL 
when laid at an angle of 40° to 50° to the ligament axis.  Utilizing the described structure, 
verification testing demonstrated that the design inputs for the toe region effect, ultimate 
strain, and resistance to fatigue and permanent elongation were satisfied. 
A prosthetic ACL with the mechanical behavior and performance provided by the 
proposed design would have advantages over the currently available ACL replacement 
options and earlier prosthetic devices.  Disadvantages associated with current options 
that would be eliminated with a functional prosthetic alternative include donor site 
morbidity and the need for the harvest operation in the case of autografts and disease 
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transmission risk, slower incorporation, and additional procurement expenses in the 
case of allografts.[5-6, 32-33]  Many of the earlier prosthetic ligaments such as the 
polytetrafluoroethlyene (Gore-tex), polyethylene terephthalate (Dacron), polypropylene 
(Kennedy LAD), and carbon-fiber (ABC) grafts had poor biocompatibility resulting in 
chronic synovitis and effusions.[6, 34-35]  PVA and UHMWPE were selected for the 
proposed design based upon a demonstrated history of good biocompatibility in other 
biomedical implant applications.[20-23]  The ultimate strength of the proposed design 
was measured in excess of 4000 N which is greater than scaffolds used for tissue 
engineered ligaments and other previous permanent prosthetic devices such as the 
Leeds-Keio, Dacron, and ABC prosthetic ligaments which were observed to be 
susceptible to rupture as a failure mode.[6, 36-38]  Though the proposed design is 
slightly inferior in strength compared to the Gore-tex graft, rupture was not observed 
among the most prominent failure modes for that device.[6, 36]   Another potential 
advantage of the proposed design is the inclusion of the toe region, which was not noted 
in the literature as a feature engineered into any of the previous devices.  Several 
authors have suggested that the inclusion of a low stiffness toe region may be important 
for prevention of creep and fatigue.[39-40] 
The mechanical evaluation had several limitations. The determination of visco-
elastic elongation from long term loading may or may not be due to creep of the 
polymeric materials.  Prediction of permanent elongation is particularly important value 
to quantify for a ligament replacement since it has been noted as one of the failure 
modes of previous devices, directly contributing to increases in anterior laxity and knee 
instability.[6, 16]  This critical issue is difficult to model in vitro and remains a limitation in 
the mechanical proof of any ligament. The clamping system for the long-term test was 
too small to hold samples of the full size of the proposed design. Therefore, samples 
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containing only half the quantity of PVA were tested.  The full ligament may distribute 
loads differently such that fatigue life may change.  Slippage during the long-term test 
prevented the determination of a definitive value for the progression of permanent 
elongation and instead made the measured value from the clamp displacement an upper 
bound for the possible permanent elongation that may have occurred.  Video or 
photographic tracking of the displacement between marks along the sample length could 
be used to directly measure sample elongation over the course of cyclic loading 
distinguishing it from the clamp slippage contributing to the change in clamp 
displacement.  Alternatively, simpler monotonic tension tests might be less susceptible 
to slippage and still provide a meaningful measurement to predict permanent elongation. 
Most of the fatigue tests were ended prior to rupture, leaving the total number of 
cycles to failure yet to be determined.  Loading was limited to 450 N as this was the 
highest value for normal activities; however, loads as high as 700 N occur in vivo.[9, 29]  
A future test may involve loading at higher and lower magnitudes continuing until rupture 
so that a complete S-n curve can be generated. 
Bending creep and fatigue are other factors that were not fully characterized in 
this thesis.  While important conceptually, these tests are not standard and may or may 
not have relevance to in vivo ligament performance.  The cyclic loading test was 
performed in force control mode as opposed to displacement control mode, though the 
native ligament or a ligament replacement would also be subject to some degree of 
displacement constraints.  Testing in force control mode provided a more strenuous 
evaluation, giving an upper bound value on the possible permanent elongation and 
fatigue in vivo.  As the ligament undergoes creep beyond a certain point, the other 
ligaments, muscles, and surrounding tissues would provide restraint to anterior 
translation, placing a limit on the total amount of displacement, and consequently, the 
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total amount of elongation.  The contributions to tibial restraint provided by the 
surrounding tissues as the ACL extends or reduces in stiffness has not been studied 
extensively and biomechanically quantified; therefore, the degree to which the measured 
results differ from what would be observed in vivo remains unclear.  Progression of 
device elongation to the degree resulting in restraint to anterior tibial translation being 
only provided by the surrounding tissues is precluded by the specified design input, 
which is exceeded before that extent of elongation occurs.[11]    
Efforts were made to simulate the in vivo environment by performing the static 
test on wet samples immediately after 24 hours of submersion in water and by 
performing the long term test with the samples submerged in water both at room 
temperature.  To better simulate the in vivo condition, a physiological fluid at 37°C might 
be used in future tests.  The tests carried out in this study were all one-dimensional 
tension tests, however other mechanisms contributing to device failure including bending 
and abrasion were not evaluated.   
Another more general limitation is the unsolved problem of developing an in vitro 
test with predictive value for the long-term in vivo condition, a weakness criticized 
previously in the literature.[41]  For example, the Gore-tex ligament was tested to failure 
at 4x109 cycles and with creep of 4% up to 3x108 cycles up to 285 N, predicted to be 
equivalent to 950 years and 70 years of in vivo use, respectively.[42]  Despite this high 
level of performance in vitro, both elongation and rupture were observed in as little as 4 
to 5 years in vivo.[41-42]  This deviation between the results predicted from in vitro 
testing and the observed clinical behavior bring to light the importance of long-term in 




PVA and UHMWPE, both noted for good biocompatibility, were utilized in a 
hollow braided rope structure designed to produce a tensile behavior similar to that of 
the native ACL.  Additionally, the design was tested with applied cyclic loading to 1 
million cycles and found to have good resistance to fatigue and permanent elongation.  
The promising results of mechanical testing of the ACL prosthesis justify more extensive 
in vivo evaluation.  A prosthetic alternative to biological grafts would provide advantages 
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CHAPTER 4   Augmentation of Bone Tunnel Healing in Anterior Cruciate Ligament 
Grafts: Application of Calcium Phosphates and Other Materials 
4.1 Introduction 
In all types of anterior cruciate ligament (ACL) reconstruction, a proportion of grafts 
fail due to a lack of healing in the bone tunnel or abrasion of the graft at the tunnel 
exit.[1] It has been suggested that stable bone tunnel healing is desirable for an ACL 
graft to be successful [2] and that the acceleration of the healing between a soft tissue 
(tendon) graft and bone may allow earlier return to functional activities and improve 
clinical outcomes.[3] Unsatisfactory osseointegration of tendon grafts used for the 
replacement of ACL may also be associated with postoperative anterior-posterior 
laxity.[4] It may therefore be expected that improvements in bone tunnel healing, 
including ingrowth or ongrowth of tissue around the graft, will improve fixation strength 
and limit graft failures by pullout and loosening.  
A variety of materials have been applied in the bone tunnels in order to improve 
healing. These range from autologous bone tissue or cells to proteins and calcium salts. 
In particular, a number of studies have proposed the use of calcium phosphate (CaP) 
materials for this purpose. The application of CaP to soft tissue attachments is becoming 
more common and has been shown to induce increases in fixation strengths and bone 
formation.  
This review examines the hypothesis that the application of CaP can improve bone 
tunnel fixation and healing in ACL grafts. The evidence for the usefulness of CaPs in 
ACL replacement is discussed along with evidence for the efficacy of CaP in other 
relevant applications and other materials used for bone tunnel healing improvement. The 
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following section gives a brief introduction to ACL replacement, mechanisms of bone 
tunnel healing, and methods commonly used to assess healing.  
4.2 Bone Tunnel Healing in ACL Replacement 
4.2.1 ACL Anatomy and Injury 
The ACL is one of two ligaments located in the centre of the knee joint. It has 
insertions in the tibia and distal femur and has a microstructure made up of collagen 
bundles surrounded by a complex matrix.[5] The ACL restricts anterior tibial translation 
and gives stability in rotation. Failure to treat this type of injury may lead to mechanical 
instability in the knee and has been linked to the early onset of osteoarthrosis.[6] 
Damage to the ACL may occur from both contact and noncontact mechanisms of 
injury.[7] It is common both in the general population and, more particularly, in those 
taking part in sporting activities. A recent study based in the United Kingdom identified 
the rate of ACL injury at 8.1 instances per 100,000 people per year.[8] Reconstructive 
surgery is routinely carried out for patients with a torn or ruptured ACL. In the USA, 
around 200,000 ACL reconstructions are performed each year.[9] The reader is referred 
to recent reviews for detailed information on ACL anatomy, function, and injury.[5, 10-11]  
4.2.2 ACL Replacement 
The ACL does not heal when torn because it lacks sufficient vascularisation. 
Surgical reconstruction is the standard treatment in sports medicine for ACL rupture.[5] 
Patients with ACL injuries are typically younger and more active than other orthopaedic 
patients, and reconstructions should exhibit good longevity, withstanding high stresses 
over millions of cycles.[12] However, the outcomes of the various techniques used for 
ACL replacement have not always been positive. Patient selection and implantation 
technique have contributed to poor results from artificial grafts, allografts, and autografts.  
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Over the past 10 years, technique has vastly improved, making autograft ACL 
replacement both common and more successful. The procedure is usually carried out 
arthroscopically using a graft from the semitendinosus tendon or the central third of the 
patellar tendon. In the latter case, the graft is harvested with a section of bone at each 
end and interference screws are used to fix the bone plug into place. These are known 
as bone-tendon-bone (BTB) grafts. A recent review suggests that there is no significant 
difference in clinical results between autograft types, with factors other than graft donor 
site (including fixation, damage to the meniscus and articular cartilage, and the 
requirement of additional surgical procedures) being the most important determinants for 
successful outcomes.[13]  
Once the graft has been harvested and prepared, often by pretensioning and the 
addition of sutures, tunnels are drilled through the tibia and femur passing through the 
attachments of the original ligament (see Figure 4.1). The graft is pulled into position and 
fixed using staples, screws, sutures, or commercially available fixation devices such as 
the cross-pins or interference screws. The surgical fixation is the weak point of the graft 





Figure 4.1   The anatomy of the bones of the knee showing the position of the 
bone tunnels from (a) frontal and (b) lateral views. The patella and patellar 
tendons are omitted for clarity.  
Autografts for ACL replacement have limitations including limited availability, and 
adverse functional changes including muscle weakness at the donor site. Conversely, 
artificial or tissue-engineered ligament grafts have some distinct advantages. These 
include the ability to control manufacturing, condition, quality, sterility and size of device 
before implantation. Mechanically tested and controlled grafts could be made available 
off the shelf and eliminate the need to create a second defect site through the harvesting 
of healthy tissue. Unfortunately, the majority of artificial ACLs have suffered from high 
failure rates due to mechanical, and in some cases biological, influences and have been 
removed from the market.[12] In the early postoperative stages, the majority of these 
failures occurred in the bone tunnels.  
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4.2.3  Bone Tunnel Healing 
The insertion of the native ACL is characterised in four layers: tendon, 
fibrocartilage, mineralised fibrocartilage, and bone. The collagen fibres of the tendon 
extend into both the fibrocartilage, and the mineralised layer. This structure is usually 
destroyed when the ligament is removed and the bone tunnel is drilled. A replication of 
this direct type of insertion may be considered desirable when assessing bone tunnel 
healing for ACL grafts.  
The mechanism by which graft-bone healing occurs depends on the type of graft 
used. For BTB grafts, healing in the tunnel resembles normal fracture healing, but may 
be a more complex process. Incorporation of the bone block in the tunnel has been 
observed as early as 16 weeks after surgery.[15] BTB grafts have the advantage of 
allowing rigid fixation of the graft in the bone tunnel.  
The tendon-bone healing process occurs through a different mechanism after 
implantation of a soft tissue graft without bone plugs.[15] Firstly, fibrovascular tissue 
forms between the graft and bone and becomes mineralised. The tendon tissue itself is 
then mineralised and incorporated into the bone.[16] Sharpey's fibres are made up of 
type I collagen and connect the periosteum to the bone. The formation of Sharpey-like 
fibres within the bone tunnel is often identified as a marker of indirect healing between 
the tendon and bone.[17] The formation of these collagenous fibres may occur from six 
weeks after surgery. However, complete bone tunnel healing of an ACL graft may occur 
as late as six to twelve months after surgery.[15] Some studies in animals have 
suggested that tendon graft incorporation occurs more slowly than BTB healing.[2]  
In addition to the choice of graft, surgical fixation, and graft position, interfacial 
motion within the bone tunnel may affect healing.[2] Graft motion within the bone tunnel 
has been shown to be inversely proportional to healing in an animal model.[18]  
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4.2.4  Assessment Techniques for Bone Tunnel Healing 
Three main factors are commonly assessed to evaluate bone tunnel healing after 
ACL replacement: functional outcome, biological structures, and mechanical properties. 
In clinical studies, functional outcome is measured by patient satisfaction, pain levels, 
and scores in the International Knee Documentation Committee (IKDC) and Knee injury 
and Osteoarthritis Outcome Score (KOOS) tests. In both clinical and animal studies, the 
biological structures in the bone tunnel are examined using noninvasive imaging. In 
animal models, these structures can also be examined by the excision and histological 
examination of the graft-bone construct. This method can be used to identify collagen 
fibres, calcified tissue and different types of cell found in the bone tunnel. Imaging 
techniques include the use of X-rays for the assessment of bone tunnel width and, more 
recently, the use of CT scanning to quantify the amount of bone tissue formed within the 
tunnels.  
Biomechanical tests are carried out on the tibia-graft-femur construct following in 
vivo studies in animals. This testing yields strength and stiffness data, as well as 
permitting observation of the mode of failure of the graft. The explanted bone-graft 
construct is mounted in a tensile test machine and, most commonly, extended to failure 
at a constant rate. The ultimate tensile strength (UTS) is recorded, and graft stiffness 
may be calculated. Direct comparison of data from these tests is complicated by 
differences in angles of flexion chosen when mounting the bones for the test as well as 
variations in extension rate, pretensioning or cyclical loading of the graft and the type of 
animal model used. In particular, the rate of extension may influence the mechanical 
behaviour of the graft.[19]  
Two distinct modes of failure are reported in tensile testing. Pullout is the term 
commonly used to indicate a failure of the fixation or tendon-bone interface. The pullout 
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strength of a graft is the force required for failure to occur by this mode. The UTS of a 
graft may refer to pullout or to midsubstance failure, which describes the rupture of the 
graft material itself or, in some cases, the deformation of the graft beyond a functional 
length. The majority of studies combine load-to-failure data, irrespective of the mode of 
failure which occurred. It is expected that failures in the early postoperative stages will 
occur in the bone tunnel, with midsubstance failure becoming the more common mode 
as bone tunnel healing advances, leaving the soft tissue graft itself as the weakest point 
in the construct.[14] A difference in the mode of failure occurring in experimental and 
control groups may therefore be interpreted as an indication of an increase in strength of 
the bone-graft interface, assuming the bone healing enhancement does not weaken the 
graft.  
4.3 Calcium Phosphates 
4.3.1  Calcium Phosphates as Biomaterials 
CaPs are considered to be safe, biocompatible materials for use in long-term 
implantation. They have been used in a variety of applications including hip stem 
coatings and bone graft materials and are commercially available in injectable, powder, 
granular, and block forms.  
CaP is bioactive: the presence of Ca and P ions allows the formation of a direct 
chemical bond between the bone and the implant.[20] The exact properties of CaPs 
depend on the Ca : P ratio, the crystallinity of the material, the presence of water and the 
purity of the material.[21] Hydroxyapatite (HA) has Ca : P ratio of 1.67 and may be 
considered as stoichiometric CaP. CaP occurs naturally in the body as the mineral 
component of bone and enamel in a form resembling HA [28]. β-tricalcium phosphate (β-
TCP) is a more quickly resorbed form of CaP. HA is resorbed over a period of decades, 
while β-TCP resorbs in months.[22] The adsorption of particles on the surface of CaP is 
82 
 
related to its crystallinity and influences the biological response to the material. CaP 
powders of different sizes have been shown to produce differing rates of bone formation 
in vivo [30]. The reader is referred to a review of bioceramics for more information on 
general uses and properties of CaP.[23]  
In this review, CaP is employed as a general term for calcium phosphate-based 
materials and is used where the specific type of CaP is not identified in the original study. 
The specific type of CaP produced or used in a study is identified when possible.  
The following section is a review of studies using CaP to improve bone tunnel 
healing. Both qualitative and quantitative assessments are considered, along with 
analysis of biomechanical changes induced by the treatments. A summary of the 
outcomes of mechanical testing from these studies is given in Table 4.1.  
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Table 4.1   Mechanical testing of different augmentation methods using calcium 
phosphates for bone tunnel healing. For ease of comparison and where available, 
data from mechanical testing at six weeks after surgery are given. Results at 
earlier and later time points are detailed in the text. Where six week data is not 
available, the nearest time period is included. aThese values were calculated from 
the average values in the preceding two columns. bReflects a difference in the 
predominant mode of failure from pullout failure in the controls to midsubstance 
failure in the treated subjects. cThis is a low-porosity CaP control, not a 
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116% 12.8±5.9 5.0±1.8c x 6 [29] 
 
4.3.2 Calcium Phosphates in ACL Reconstruction 
4.3.2.1  Injectable Materials 
A short-term biomechanical study on the effects of CaP cement on the pullout 
strengths of tendon grafts for ACL replacement was carried out using a rabbit model by 
Tien et al.[26] Grafts were implanted bilaterally and held in place with sutures. One graft 
in each subject was then further fixed in place by injection of the bone cement into the 
tunnel. The application of the cement led to increase in pullout strength, with the average 
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strength more than doubled as measured two weeks after surgery. Biomechanical 
testing was not carried out at later time points. Histological examination showed bone 
islands growing between the cement, bone and tendon as early as three weeks after 
implantation. Bone development extended to 24 weeks after surgery. In the 
noncemented control subjects, no bone formation was found in the interfacial gap.  
These findings are supported by Huangfu and Zhao, who examined the use of 
injectable resorbable TCP in bone tunnels in a canine model.[25] The grafts filled only 
the articular ends of the tunnels and were fixed using sutures. The CaP was then used to 
fill the sections of the tunnels not filled with the graft. Although the TCP was not 
specifically injected into the tendon-bone interface, it was observed to be present in that 
area during histological evaluations. At 12 weeks after implantation, in the experimental 
grafts, areas resembling a normal ACL insertion appearance with fibrocartilage and 
calcified bone were present. The remainder of the interface showed a regular Sharpey-
like fibre link from tendon to bone. Bone development in the controls was found to be 
slower, with no calcified tissue or fibrocartilage formed. The pullout strength of the grafts 
was found to be increased by the presence of the TCP up to six weeks after surgery. 
While earlier results were statistically significant, the significance of data gathered at the 
six week time point was limited by the size of the sample. From eight weeks after 
surgery, all failures in the test group occurred by mid-substance rupture. This study 
established a clear pattern of improved intratunnel healing up to 12-weeks after surgery.  
The authors of these studies do not discuss whether the observed improvement 
in healing was the result of the restriction of graft movement in the tunnel due to the 
presence of the cement or of increased bioactivity due to the chemical effect of the CaP. 
Huangfu and Zhao do, however, speculate that the use of a resorbable material is 
preferable if a normal ligament-bone insertion is to be developed.[25]  
85 
 
In a further study examining the effects of CaP-based cements, a cement 
containing brushite (dicalcium phosphate dihydrate) was shown to increase fixation 
strengths in ACL grafts up to 12 weeks after implantation in a rabbit model.[30] The 
increase in strength was 118% six weeks after surgery and 55% at the 12 week time 
point. The cement was injected into the bone tunnels before the grafts were pulled into 
place. In vivo, the cement degraded to leave granules of β tricalcium phosphate between 
the bone and tendon. The majority of failures in the treated group occurred in the intra-
articular section of the graft, whereas control grafts failed by pullout. The increase in 
strength corresponded with larger amounts of bone formation around the tendon graft.  
Gulotta et al. investigated the use of an alternative to standard injectable CaP 
materials by adding magnesium to the cement.[27, 31] While standard CaP cements act 
as grout, filling the space between the bone cavity and the graft, the inclusion of 
magnesium was intended to give this product adhesive properties. The study was 
carried out in a rabbit model, and grafts were held in place using sutures. In the control 
group, no cement or adhesive was applied. Three weeks after surgery, the strength of 
the experimental group was the same as that of the controls. However, this may have 
resulted from incomplete hardening of the adhesive at this stage. Six weeks after 
surgery failure loads were 65% higher than the controls. The failure of the grafts is 
described as occurring at the “graft-tunnel junction.” The authors note that although the 
graft fixation strength was increased in this study, it did not achieve the strength of an 
unoperated tendon. The average ultimate load-to-failure of the native rabbit ACL has 
been shown in a previous study to be 351.8 ± 41.6 N (Labs 2002 cited by [27]), while 
mean load to failure in the treated group was 71.7 N.[27] This study also made use of 
µCT scanning to quantitatively measure the increase in bone volume in the tunnels. A 
significant increase in total intratunnel bone volume was observed in the experimental 
86 
 
group when compared to control at six weeks. Staining also showed more cartilage 
tissue and less fibrous tissue formation in the bone tunnels. The increase in cartilage 
formation was shown to be statistically significant at six weeks after surgery, as 
evidenced by an increased area of metachromasia (79 556.2 ± 61 664.0 µm2 compared 
with 2806.2 ± 6 873.7 µm2 for the control).[27]  
Although the results of this study show improvement when compared to controls 
in which no bone adhesive was used, the role of the magnesium in this improvement has 
not been proven. When comparing the results of this study to others using CaP cements, 
there does not appear to be an increase in strength corresponding to the presence of the 
magnesium (see Table 4.1).  
It is important to note that the use of bone cements in ACL graft attachment 
without additional surgical fixation has been shown to result in inadequate fixation.[32] 
An in vitro study in porcine bone compared various methods of surgical fixation, 
including a calcium carbonate-containing cement. High levels of graft slippage within the 
bone tunnels were observed during cyclical loading, showing the bone cement to be 
unsuitable as a primary fixation method.  
A different injectable material was proposed by Ishikawa et al.[33] Collagen gels 
containing HA for the improvement of tendon-bone healing were tested in a rabbit model. 
A direct bond was shown to be formed between the tendon and the bone in the presence 
of the gel, which contained 60% HA and 40% collagen. The HA particles were up to 200 
µm in size. The presence of both the collagen and the HA resulted in collagen fibres 
from the tendon being interwoven into newly formed bone around the graft. In the 
controls, in which no gel was applied, amorphous tissue formed in the tendon-bone 
interface. The effect of the improved interface on the mechanical performance of the 
graft was not assessed.  
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4.3.2.2  Bone Screws in ACL Reconstruction 
A further means of introducing CaP into the bone tunnel is to include them in the 
material to be used in the fixation of the graft. This commonly involves the use of 
resorbable fixation screws containing CaP. A number of studies have examined the use 
of CaP-containing interference screws for soft tissue graft fixation. Hunt et al. compared 
bone tunnel healing for grafts fixed with commercially available PLLA-HA composite 
screws with that for grafts fixed with simple PLLA screws in ovine models over a period 
of 12 months.[34] New bone formation along the perimeter of the screw threads was 
found to be significantly increased in screws containing HA than those containing PLLA 
alone. These observed increases in bone ingrowth and mineralisation can be directly 
attributed to the presence of the HA as the mechanical fixation of the two types of screw 
is comparable. The mechanical properties of the fixations and the phenomenon of bone 
tunnel widening were not investigated.  
The same composite screws (HA/PLLA) have also been examined in vivo in a 
clinical setting in 100 patients.[35] The results supported those of Hunt et al., with a 
reduction in tibial tunnel widening occurring around the screw in cases where the 
composite screws were used. It is interesting to note, however, that above the screw, in 
the section of the tunnel containing tendon graft, bone tunnel widening was unaffected 
by the type of screw used. This suggests that the effect of the HA is highly localised. The 
improvement in bone tunnel healing around the screw did not correspond to any 
difference in clinical outcome or knee laxity. However, this study was carried out 12 
months after surgery. More differences between the experimental and control groups 
may become apparent at later time points.  
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4.3.2.3  Precipitation of CaP 
In contrast with other methods which seek to apply CaP in the bone tunnel or 
include it in the fixation, Mutsuzaki et al. deposited a layer of CaP directly onto a tendon 
graft.[28, 36] This was achieved by soaking the ends of the tendon in Ca-containing 
solution and a PO4-containing solution in turns for 30 seconds each. The complete 
soaking process took ten minutes, and the CaP layer deposited was over 100 µm thick. 
XRD analysis showed the deposited material to be made up of low-crystallinity apatite 
and dicalcium phosphate dihydrate. The deposited CaP was examined by transmission 
electron microscopy and was shown to be made up of needle-like crystals formed on 
and between the collagen fibrils of the tendon.[28]  
When implanted in white rabbits, the “hybridized” tendons appeared to heal faster 
than controls which had been soaked only in saline. As early as 5 days after surgery, 
increased numbers of osteoclasts and osteoblasts were observed in the experimental 
tendons compared to the controls. Over a period of four weeks, tendon-bone healing 
was more advanced in the healing group, particularly in the formation of a direct tendon-
bone bond, without the layer of interfacial fibrous tissue observed in the controls.[36] 
Although the later study implanting hybridized tendons in goats failed to find a 
corresponding increase in UTS six weeks after surgery, a slight change in the failure 
mode was observed between experimental grafts and controls.[28] Failures in the CaP 
treated grafts occurred in the intra-articular portion, whereas three of the seven control 
grafts failed by pullout from the bone tunnel. The authors claim that this implies that the 
fixation in the CaP grafts is stronger than that in the controls and may be related to the 
earlier observation of improved bone tunnel healing; however, the assessment is not 
statistically significant. The studies were carried out six weeks after implantation.  
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In addition to studies directly investigating bone tunnel healing, CaPs have been 
used for enhancement of the attachment of other soft tissues grafts to bone. The 
following section presents the outcomes of investigations into these applications of CaP-
based materials.  
4.3.2.4  Calcium Phosphates in Other Relevant Applications 
The use of porous CaP blocks has been suggested as a means of attaching 
tendon to bone. Although their study was not based on an ACL replacement procedure, 
Omae et al. examined healing between two types of porous CaP and tendon grafts 
implanted with them in rabbit femora.[29] The two materials tested were both 
commercially available in Japan. The first had a pore size around 150 µm, was 72%–
78% porous and was made up predominantly of interconnected pores. The second 
material had a pore size of 50–300 µm and 35%–48% porosity with a lower level of pore 
interconnection. Wedges or cylinders of the CaP were implanted in the bone with 
cylindrical holes allowing the tendon graft to be passed through the block. The material 
with the interconnected porosity induced the best healing, with early formation of 
collagenous tissue followed by bone ingrowth into the material. Twenty-four weeks after 
surgery the tendon was found to be in direct contact with the bone grown into the CaP 
material. The amount of biological ingrowth into the other material was found to be lower. 
This was a predictable outcome due to the lack of interconnectivity in the porous 
material. The improved ingrowth in the interconnected material resulted in an increase in 
tendon pullout strength. This paper does not, however, comment extensively on the 
healing between the CaP and the tendon, focussing instead on the extent of bone 
ingrowth into the porous material. An extension to this study found that seeding bone 
marrow stromal cells into the interconnected CaP ceramics further improved bone 
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attachment.[37] This procedure could be considered a step towards replicating a BTB 
graft by artificial means.  
CaP is also used as a synthetic bone graft and has been proposed for use in a 
variety of forms as a scaffold component for tissue engineering. Some of these 
applications may be transferable to ACL graft fixation, particularly in the development of 
artificial grafts. The following brief review summarises investigations of CaP which may 
be relevant or applicable to ACL graft development.  
Al Munajjed and O'Brien produced collagen scaffolds and coated them in 
precipitated hydroxyapatite by serial soaking in calcium chloride and ammonium sodium 
hydrogen phosphate solutions.[38] The scaffolds produced were not sufficiently strong 
for implantation in bone without support, having a compressive modulus of 10.3 KPa. 
However, this material combination may have applications in bone tunnels, particularly if 
the collagen-CaP structure could be tailored to encourage regrowth of a gradual 
structure mimicking the natural ACL insertion.  
Mavis and Demirtas used a simulated body fluid-like solution to deposit 
nanoscale HA particles on polycaprolactone nanofibres. The aggregation of the HA did 
not compromise the porosity of the resulting scaffold. The presence of HA was shown to 
increase the attachment and proliferation of osteoblast-like (MC3T3) cells on the 
scaffolds in vitro.[39] Other HA-containing polymer composites proposed for bone tissue 
engineering include HA-Poly(ester urethane), which was shown to retain its viscoelastic 
properties and biocompatibility after HA incorporation [40] and HA-polyamide.[41]  
The development of synthetic materials for the replacement of articular cartilage 
has advanced in recent years. The production of compliant materials which mimic more 
closely the properties of natural cartilage necessitates the development of a means of 
fixing the graft to the underlying bone. As suggested by Sinha and Guha, the 
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incorporation of HA into an appropriate scaffold material may facilitate fixation to bone 
tissue.[42] In this study, HA-PVA hydrogels were obtained via the freeze-thawing of a 
PVA emulsion in which HA particles had been made to precipitate. The resulting 
scaffolds were porous and the authors suggest that it may be possible to induce a 
gradient in the HA concentration through the structure, making it suitable for bone-
cartilage tissue engineering.[42] Similarly, Wu et al. investigated a PVA hydrogel for 
cartilage replacement.[43] The HA particles were found to increase elastic modulus of 
the material. In vitro, the presence of HA also increased apatite formation when 
submerged in simulated body fluid. This is often interpreted as a sign of bioactivity and is 
a commonly observed phenomenon in HA-containing materials.[44]  
These promising in vitro indications are complemented by a further study which 
included an in vivo evaluation. An HA-PVA hydrogel construct with a graduated HA 
content was fabricated by a sol-gel method by Zheng et al. and tested both in vitro and 
in vivo.[45] PVA does not usually adhere to cartilage and living bone. After immersion in 
SBF, only HA-containing materials were coated in a bio-mineralised CaP layer. This 
corresponded to good bonding and osteoid development between the subchondral bone 
and the synthetic material when implanted in the femoral heads of rabbits. The authors 
considered HA-PVA to be a promising articular cartilage construct, particularly with 
respect to its bone integration.  
The addition of HA to PVA in order to improve cell attachment properties was also 
put forward by Degirmenbasi et al.[46] for use in articular cartilage replacement. The 
HA/PVA/collagen scaffolds produced were porous, a feature desirable for the 
encouragement of bone ingrowth. However, the pores produced measured no more than 
500 nm, a dimension too small to allow bone ingrowth to occur.[47]  
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An alternative approach to improving PVA attachment to bone in cartilage repair 
is to coat the hydrogel attachment surface with a layer of amorphous HA to provide an 
interface. One study coated the bone-contacting surfaces of a PVA hydrogel construct 
with amorphous HA using pulsed laser deposition (PLD).[48] This technique has the 
advantage of allowing targeted deposition which, unlike soaking methods, leaves the 
articular surface of the PVA clear of HA. When tested in vitro, the presence of the 300 
nm thick layer of HA greatly increased the attachment and proliferation of murine 
fibroblasts (L929). The investigation was continued with a study of osteoblast cell 
(MC3T3) attachment to HA-covered gels.[49] Cell numbers were higher on the HA than 
on the hydrogels alone, as were both alkaline phosphatase and osteocalcin production. 
The presence of the HA encouraged osteoblast differentiation. The authors consider this 
an indication that HA coating by PLD is an effective way of fixing PVA hydrogels to bone.  
A recent review considered the range of materials applied for the enhancement of 
intra-tunnel healing.[2] The following section briefly presents these strategies for the 
augmentation ACL graft incorporation before comparing their results with those found for 
CaPs. Table 4.2 summarises the effects on fixation strengths documented for some of 
the different methods.  
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Table 4.2   Mechanical testing of various augmentation methods for bone tunnel 
healing. For ease of comparison and where available, data from mechanical 
testing at six weeks after surgery are given. Results at earlier and later time points 
are detailed in the text. Where six week data is not available, the nearest time 
period is included. aThese values were calculated from the average values in the 
preceding two columns. bReflects a difference in the predominant mode of failure 


























GCSF  114% 99.45±25.5 31.97±11.9 √ 4 [50] 
BMP-2 
(low dose) 






210±66 171±20 √ 4 [51] 
BMP-7 77% 380±33 215±44 √ 6 [52] 
Xenograft-
derived BMP 
52% 64.71±21.36 42.69±15.03 x 6 [53] 
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4.4 Alternative Augmentation Materials 
4.4.1  Soft Tissue Grafts 
4.4.1.1  Biologics 
The use of artificial or processed bone proteins and growth factors to augment 
healing in ACL replacement grafts has been investigated. Granulocyte colony stimulating 
94 
 
factor (GCSF) causes the production of granulocytes and stem cells in bone marrow. It 
has been shown to induce the differentiation of neutrophils (cells of the immune system 
associated with inflammation) and to encourage angiogenesis and the differentiation and 
migration of mesenchymal stem cells. Sasaki et al. therefore proposed that the 
application of GCSF may encourage accelerated bone tunnel healing. GCSF was 
incorporated into a gelatin hydrogel to control its release and applied during ACL 
reconstruction in adult beagle dogs. In biomechanical tests, the treatment resulted in a 
large increase in the failure load (see Table 4.2). Histological investigations also 
indicated accelerated bone development around the GCSF treated grafts.[50] The 
majority of experimental grafts failed midsubstance while untreated grafts failed by 
pullout, indicating an increase in the bone-graft interface.  
Bone morphogenetic proteins (BMPs) are signalling proteins that influence tissue 
structures in the body. They have been shown to have a role in skeletal development. 
Both BMP-2 [56] and BMP-7 [52] have been shown to increase graft fixation strengths 
when applied in the bone tunnels in animal models. Likewise, BMP-7 was shown to 
increase the volume of bone formed within the tunnels six weeks after implantation.[52] 
However, one study found that the difference in strength between grafts treated with 
BMP-2 and controls diminished over time (as measured eight weeks after surgery).[51] 
This implies that these products induce faster healing, but not necessarily stronger 
fixations in the long-term.  
Chen et al. advanced the study of the use of BMPs by combining them with 
implanted periosteal progenitor cells.[4] The protein was tested in soluble form (BMP-2 
alone) and tethered to the surface to prevent dissipation (BMP-2 tethered with hyaluronic 
acid). At three and six weeks after surgery, more calcium and collagen were found in the 
soluble BMP-2-containing samples than in controls, with significantly increased amounts 
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identified in the hyaluronic-acid tethered samples. At three weeks after surgery, the 
mode of failure was changed in the hyaluronic-tethered BMP-2 group, in which no 
samples failed by tibial pullout. Failure strengths were higher in the treated groups than 
in the control, with the hyaluronic-acid tethered grafts the strongest six weeks after 
surgery. Similar results to those found for BMPs were observed after application of a 
bone-derived extract (Bone Protein, Sulzer Orthopaedics).[57] In tensile tests, failure 
loads were significantly higher than in control groups at two, four and eight weeks after 
surgery, although the failure modes were unchanged.  
Bone samples can be used as a source of natural BMPs. Pan et al. studied the 
effect of applying recombined bone xenograft within the bone tunnels after ACL 
replacement.[53] The xenograft was used to produce BMPs, which were then mixed with 
cancellous bone and formed into cylinders which were attached to the ends of tendon 
grafts and implanted in the tibial and femoral bone tunnels in rabbit models. The average 
load to failure of the treated grafts at this time point was 58% greater than that of the 
controls. Failure strength at 12 weeks after surgery was also increased.  
Demineralised bone matrix (DBM) is a further source of BMPs which has been 
proposed as a means of enhancing tendon-bone healing in rotator cuff repair. 
Application of this material has been shown to increase fixation strengths between 
tendon and bone in an ovine patellar model. The presence of the DBM induced an 
increase in the growth of fibrocartilage and mineralised fibrocartilage at the tendon-bone 
interface.[58]  
These studies demonstrate the importance of the mode of delivery chosen for 
these proteins, as shown by the differences in results between tethered and nontethered 
molecules. Longer studies would be beneficial in order to properly evaluate their efficacy. 
BMPs have been applied in other bone repair applications, producing promising results, 
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and BMP-containing products have been approved by regulatory bodies. The reader is 
referred to a recent review for further information.[59]  
4.4.1.2  Cells 
As well as the use of biologics (which include BMPs and GCSF), the application 
of materials seeded with mesenchymal stem cells (MSCs), from which osteoblasts are 
derived, has also been shown to increase failure strengths and improve bone tunnel 
healing. In one such study, MSCs were applied to the surface of a graft, seeded in a 
fibrin glue carrier. The difference in strength between the experimental and control 
groups was shown to increase over time after application of these cells up to eight 
weeks after surgery. This trend is in contrast with those observed for other interface 
healing enhancement materials. Histological examination showed the presence of type II 
collagen at the tendon-bone interface eight weeks after surgery. Histological 
characteristics of the interface were found to be similar to normal rabbit ACL 
insertions.[54] The development of insertion architecture comparable to that of the native 
ACL is desirable if it results in comparable strengths and loading responses in the graft.  
4.4.1.3  Periosteum 
The augmentation of intra-tunnel sections using periosteum has been proposed 
due to the osteogenic potential of periosteal cells and tissue. A number of studies [2, 60-
61] have found improvements in intra-tunnel bone development and an increase in mean 
load to failure using this technique. A further study found that while the periosteum 
treated grafts displayed higher strength than the control grafts treated six weeks after 
surgery (see Table 4.2), the difference at 12 weeks was not statistically significant. An 
additional group of grafts in this study were treated with bone marrow in addition to 
periosteum. No statistically significant difference was observed in fixation strength six 
weeks after surgery. However, at 12 weeks an increase of 47% was observed.[55]  
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The harvesting process for periosteal tissue is fast, requiring only three additional 
minutes of surgery.[60] In animal models, the addition periosteal tissue to tendon grafts 
provided increased strength and resulted in a change of failure mode compared to 
controls.[3] This technique has the advantage of delivering autologous bone-forming 
cells to the bone tunnel. It is also possible that the presence of the layer of periosteal 
tissue in the tunnel provides some mechanical benefit in limiting the movement of the 
graft within the tunnel.  
Tendon grafts remain the “gold standard” in ACL replacement, despite various 
artificial grafts which have been proposed over the last thirty years. Although ultimately 
these artificial grafts were not considered successful, useful information may still be 
obtained from attempts to encourage long term fixation by improving bone healing 
around them. The following section reviews additional means for improving graft fixation 
that has been employed when implanting artificial ACL grafts.  
4.4.2  Artificial Grafts 
Prosthetic grafts for ACL replacement have been available since the 1970s. 
Examples of the materials used for these devices include carbon, Gore-Tex, Dacron, 
polypropylene, and polyethylene terephthalate (PET). Generally, outcomes of these 
devices have been poor, leading to the withdrawal from the market of the vast majority of 
artificial grafts. Failure modes for artificial grafts have included intra-articular rupture, 
foreign body reactions and loosening, abrasion at the bone tunnel exit, failure of fixation 
and poor intratunnel healing.[12] Abrasion at the bone tunnel exit has been shown to be 
significantly reduced by chamfering of the corners of the bone around the tunnel.[1] A 
number of studies have considered the promotion of intra-tunnel healing in artificial 
grafts. For example, the Leeds-Keio ligament, a polyester mesh intended to act as a 
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scaffold for soft tissue repair, was fixed in place using bone plugs, replicating the BTB 
type autografts.[12]  
Following disappointing outcomes for artificial grafts due to wear and abrasion, 
the inclusion of biological components to allow for graft remodelling has been the subject 
of several papers. In the native ACL, the primary zones of the natural ligament-bone 
insertion structure (ligament, fibrocartilage, mineralised fibrocartilage, and bone) are 
populated by different cell types. Spalazzi et al. recently developed a three-phase 
scaffold designed to mimic this interface.[62] This single structure was made up of a 
poly(lactic-co-glycolic acid) (PLGA) mesh for fibroblast and soft tissue culture, PLGA 
microspheres for the transition zone and sintered PLGA and bioactive glass for the bone 
section. The device is suggested for use as a graft collar in ligament grafts. It has been 
shown to support the growth of multiple cell types (seeded in vitro) when implanted 
subcutaneously in an animal model but is yet to be tested functionally.  
Chitin is a biopolymer found in the exoskeletons of crustaceans and insects. It is 
considered to be a bioactive material. One study proposed the application of chitin as a 
means of improving the attachment of artificial ligaments. This in vivo study in a rat 
model showed that the application of chitin/chitosan to a polyester fabric significantly 
increases pullout strength and bone formation in the short term.[63] The pullout strength 
of the treated samples was found to be twice that of the nontreated polyester controls 
two weeks after implantation. The advanced bone growth is attributed by the authors to 
the bioactivity of chitosan, including its ability to promote osteoblast attachment and 
extracellular matrix production. However, images of the coated and control materials 
also demonstrate that coating the fabric significantly increases the surface area available 
for cell attachment and this may also play a role in the advancement of bone formation.  
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A study of bone ingrowth into Gore-Tex PTFE artificial ligaments suggested that 
the porosity of the graft fibres, which were 75% air by volume, was key to allowing bone 
ingrowth. This suggests that the provision of porosity for tissue ingrowth at the bone-
graft interface should therefore be considered important when applying bulk materials 
within the bone tunnel. A stable fixation was found within the bone tunnels up to 18 
months after implantation in an ovine model.[64] However, these ligaments were later 
removed from the market due to problems including loosening and synovitis, along with 
two documented cases of osteolysis.[65] The implications of these findings as well as 
those for CaP based materials are considered in the discussion section.  
4.5 Discussion 
4.5.1  Test Methodologies 
Differences in methodology render direct quantitative comparisons between 
these studies complex. Results of biomechanical testing may be influenced by rates of 
extension, clamping of samples, and chosen angles of flexion. These are not 
standardised across the testing included in this review. The type of animals used is 
inconsistent, with rabbit, porcine, and canine models all being common. The number of 
subjects also varies in animal tests.[28, 51]  
Time periods for mechanical testing range from two weeks to 52 weeks. The 
majority of studies last between six and 12 weeks. As the graft healing progresses, 
differences between treated groups and controls tend to change and do not always 
follow predictable patterns. Although differences are visible at 6 weeks and sometimes 
earlier, this may not be a predictor of increased strength later, as shown by the results of 
Wen et al.[30]  
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A change in failure mode may be considered a simple means by which to 
measure at what point the bone tunnel ceases to be the weakest point in the graft. The 
change in failure mode in biomechanical testing may be therefore considered a useful 
indicator of improvement over control procedures. It should be noted, however, that if the 
graft material degrades over time, the mode of failure may change even if the fixation 
strength has not increased. Examination of failed grafts for assessment of degradation is 
not commonly carried out.  
The extent to which the observed improvements in animal models may relate to 
changes in outcome for the patient is unclear. Clinical studies regarding this type of 
application of CaPs are rare. The use of CaPs in resorbable screws, for example, 
produced improved results in animal models but did not induce a clear improvement in 
outcome for patients.  
4.5.2  CaPs for Bone Tunnel Healing 
Broadly, many of these strategies for the augmentation of bone tunnel healing in 
soft tissue grafts have been shown to have promising effects. All of the CaP-based 
materials were judged to have induced improvements in the biological structures forming 
in the bone tunnels during healing. The improvements included increases in bone mass 
and changes in the nature of the tissue forming in the tunnels. In the majority of cases, 
UTS increased (see Table 4.1), suggesting that the application of these materials 
increases fixation strength in the short to midterm. However, increases in fixation 
strength do not always introduce a change in failure mode compared to that observed in 
the controls. Longer-term studies are desirable in order to properly assess increases in 
fixation strength in ACL grafting and to provide more detailed information for the planning 




With respect to both increases in fixation strength and changing the mode of 
failure, the application of CaPs has been shown to produce results comparable to, and in 
some cases better than, those obtained using materials whose application is more 
challenging (see Table 4.2).  
When considering which technique to apply for the improvement of intratunnel 
bone healing, it is important to evaluate the complexity and cost of the method with 
respect to its efficacy in improving fixation. In the future, the development of devices 
facilitating the application of GCSF or mesenchymal stem cells, both of which have been 
shown to produce significant improvements in strength, may be desirable. However, for 
immediate improvement in bone tunnel healing, the application of existing CaP products 
such as bone cement seems to significantly improve fixation at a low cost and using a 
simple procedure and existing approved materials. CaP-based materials were shown to 
increase fixation strengths and advance healing at the tendon-bone interface. They are 
widely used biomaterials which are simple to apply and are likely to be among the least 
expensive of the proposed methods. They have a long-standing safety record and Good 
Manufacturing Practices (GMP) for them are well established.  
The improvements in bone tunnel healing in ACL grafts fixed using CaP is usually 
attributed to their chemical composition. Bone mineral is a nonstoichiometric form of 
CaP containing additional elements such as silicon and magnesium. Although the exact 
properties of CaPs depend on the manufacturing processes used to obtain them, they 
are generally considered to be bioactive. There is insufficient evidence to show whether 
any particular phase of CaP is preferable in this application.  
In addition to the changes in the chemical environment around the healing 
interface, the application of CaP in injectable or bulk form may offer mechanical 
advantages in ACL graft fixation. In order for tendon-bone interfacial healing to occur, 
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movement between the two faces must be limited. Where an extensible graft, such as a 
tendon graft, is inserted into the bone tunnel, the application of bone cement or porous 
blocks may provide additional fixation proximal to the joint space, limiting intratunnel 
movement of the graft and facilitating healing. The improvement of bone tunnel healing 
in this manner may also limit abrasion and wear of the graft due to the restriction of 
intratunnel graft motion.  
While CaP-containing screws are commercially available and clinical evaluation 
is possible, the application of CaP cement in the bone tunnels does not appear to have 
been the subject of a clinical study. In vitro studies of the application of CaP cements in 
the bone tunnel have shown significant and consistent improvements in fixation strength 
and healing of bone tissue in and around the tunnels. This technique could be simply 
applied and merits further examination.  
4.5.3  Application to Artificial Graft Materials 
For the attachment of future artificial grafts, techniques proposed for use in 
biological grafts may also be of use. Artificial grafts offer the advantage of being able to 
design both the graft material and the bone-graft interface. Materials which are chosen 
for their ligament-like properties may be adapted for bone attachment by the application 
of CaP-based materials. The combination of CaP with PVA, a material which usually 
resists cell attachment, has been shown to improve its attachment to bone. These 
techniques for combining polymeric materials with CaP could be adapted to improve the 
attachment of an artificial ACL graft.  
4.6 Conclusions 
This review examines the hypothesis that the application of CaP can improve 
bone tunnel healing after ACL replacement. In general, ACL-bone tunnel fixation strength 
can be increased by approximately 100% through the incorporation of CaP and other 
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techniques. The application of growth factors and stem cells merits further investigation 
but is not immediately clinically applicable. The use of commercially available CaP 
cements induced changes in all the major indicators: bone formation, biomechanical 
strength, and mode of failure in biomechanical testing. While the evidence is not 
conclusive, it suggests that CaP materials perform as well as more complex biologic or 
cell-based solutions in this application. Studies show that the presence of CaP induces 
improvements in healing as investigated using histology and medical imaging as well as 
increases in strength and changes in mode of failure in mechanical testing.  
A clinical study into its use to augment fixation and bone tunnel healing in ACL 
grafts is merited. More specifically, a study linking experimental fixation strengths in a 
suitable animal model to clinical outcomes in human subjects would be of great benefit, 
both in establishing the efficacy of this treatment and in helping to establish what 
parallels, if any, can be drawn between biomechanical testing in animals and clinical 
results.  
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CHAPTER 5   Kinematic Evaluation of Anterior Cruciate Ligament Reconstruction 
with a Synthetic Prosthesis 
5.1 Introduction 
The anterior cruciate ligament (ACL) is one of the four major ligaments of the 
knee, coursing from a posterior position on the medial wall of the lateral femoral condyle 
to a more anterior position on the tibial plateau.[1]  This orientation enables the ACL to 
function as the primary restraint to anterior tibial translation (ATT), maintaining proper 
relative tibiofemoral orientation and providing joint stability throughout the range of knee 
motion.[2-3]  Additionally, the ACL is the secondary restraint to internal tibial and valgus 
rotational loads.[4]  Collagen fibers in the native ACL are aligned along the ligament axis 
to bear tensile loading and exhibit a periodic crimp pattern resulting in a low-stiffness toe 
at low strains and increasing stiffness at greater strains as the collagen is 
straightened.[5-7]  Several authors have suggested that the presence of the toe region 
may be important for the prevention of creep and fatigue, however, we were unable to 
find documented experimental evidence demonstrating this.[8-9] 
ACL disruption is a relatively common knee injury with an incidence rate 
estimated to be approximately one out of 1750 in persons from 15 to 45 years of age in 
the United States.[10]  The ACL has a poor intrinsic healing capacity due to a lack of 
significant vascularization in the adult; therefore, reconstruction is the recommended 
treatment for ACL rupture.[11-12]  Currently, autografts and allografts are used for ACL 
replacement; however, drawbacks such as donor site morbidity and lack of availability 
still leave room for improvement.[12-13]      
   In the current study, a computational finite element model of the knee was built 
and validated.  The model was then used to evaluate the kinematic behavior of a knee 
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reconstructed with an ACL prosthesis for comparison with the intact knee.  Installation 
factors, specifically the tension at which the prosthetic is placed and the femoral tunnel 
orientation used, were evaluated to determine how they affect functional restoration.   
Graft tension, generally determined by the amount of extension applied to the 
intra-articular section of the ligament-replacement prior to attachment to the bone, is 
known to be an important factor affecting knee function.[14-21]  However, the precise 
value for the ideal tension for each combination of fixation and graft type has yet to be 
completely determined from empirical or clinical experience.  Cadaver and short-term 
animal studies have indicated that low initial graft tension can result in joint laxity and 
irregular kinematics while high tension reduces laxity and can limit extension, cause 
posterior subluxion of the tibia relative to the femur, increase compressive forces on the 
articular surface, and accelerate joint degradation.[16, 19, 22-24]  Most long-term in vivo 
studies have focused on biological grafts; however, the long-term behavior of frank 
replacement prosthetic devices, which are expected to retain their original properties in 
vivo, should differ since they do not remodel after implantation.[16]  A prosthetic device 
may be subject to non-biological effects which occur prior to osseointegration, such as 
viscoelastic creep, fixation slippage, loosening, and fatigue; and if these are quantified, 
the relationship between initial and long-term tension and length may be extrapolated in 
a more straightforward manner than with biological grafts.  Many types of fixation 
devices are successfully used to secure grafts to the femur and tibia without slippage 
and with sufficient strength and stiffness to support osseointegration and sustain loading 
during rehabilitation.[25]  The present study focuses on the long-term case of a 
reconstructed knee in which a prosthetic ACL has already osseointegrated, forming a 
rigid attachment with the bone.  The sensitivity to changes in tension were examined in 
terms of anterior laxity to define a range of acceptability for placement of the prosthetic. 
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In an ACL reconstruction, two common orientations in which the femoral tunnel 
can be drilled are (1) transtibially or (2) through an auxiliary anteromedial portal, with 
each method having advantages and disadvantages.[21, 26-28]  Using the transtibial 
technique (TT), the femoral tunnel is drilled directly through the tibial tunnel with the 
knee flexed to approximately 90°.  Transtibially placed biological grafts have been shown 
to be effective at restoring anterior-posterior translational stability; however, this 
technique places the tunnel more vertically and outside of the native ACL footprint, 
which some authors have associated with inferior rotational stability, particularly with 
regards to limiting internal tibial rotation.[27-28]  Alternatively, the femoral tunnel can be 
drilled independent of the tibial tunnel through an auxiliary anteromedial (AM) portal 
adjacent to the patella with the knee flexed to 110° to 130°.   Drilled from the 
anteromedial portal, the femoral tunnel exit lies within the footprint of the native ACL 
which may result in better rotational stability; however, this method is slightly more 
invasive, requiring the extra portal.[27-28]  Controversy exists over which technique is 
superior, with the selection often coming down to surgeon preference and experience.  
In the current study, the two orientations were compared in terms of anterior laxity, 
rotational stability, and stress concentrations. 
A prospective design for a prosthetic ACL may be a composite structure 
consisting of polyvinyl alcohol (PVA) and ultrahigh molecular weight polyethylene 
(UHMWPE) fibers.  The design exhibits a ligament-like toe during extension which we 
hypothesize may be advantageous for the application of ACL replacement.  The effect of 
the toe region was studied by comparing knees reconstructed with the non-linear 
prosthetic to the same with a hypothetical linear device.   These reconstructions were 
compared in terms of anterior laxity and stress concentrations to determine if the 




5.2.1 Building the knee models 
Magnetic resonance imaging (MRI) data of the fully extended right knee of a 41-
year-old female was obtained from surgeons at Hôpital Bon-Secours in Metz, France.  
3D Slicer v3.6, an open-source application for medical image computing, was used to 
build an anatomically accurate virtual model of the knee from the DICOM data.[29-32]  
The tibia, femur, fibula, and menisci, were outlined in each image layer and compiled to 
create a three-dimensional model of each structure.  Additionally, the footprints of the 
anterior and posterior cruciate ligaments and medial and lateral collateral ligaments were 
noted from the MRI and marked on the virtual femur and tibia. 
The bones and menisci structures were then imported as parts into a finite 
element computational mechanics model (Abaqus/CAE 6.9) and assembled in their 
correct relative orientation.  ACL-intact and the ACL-deficient models were created as 
controls with which prosthetic reconstructed knees could be compared.  The four 
ligaments were each modeled as dual-bundled structures, comprised of an anterior and 
a posterior bundle, consistent with anatomic and biomechanical observations.[1, 33]  
Each bundle was modeled as a single one-dimensional axial element with non-linear 
elasticity and initial strain values extrapolated from experimental data reported in the 
literature.[34-37]  The centers of the footprints of each bundle were estimated from the 
MRI and selected as the attachment points.  The bones were modeled as rigid structures 
and the menisci as linearly elastic solids with a Young’s modulus of 59 MPa and a 
Poisson’s ratio of 0.49 as in a previous study.[34]  A pathway was imposed for passive 
knee flexion consistent with knee motion studies describing the normal range of relative 
displacement and rotation between the femur and tibia during flexion from 0° to 90°.[38-
39]   
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Reconstructed knee models were created in which the ACL was replaced with a 
9-mm diameter, cylindrical prosthetic ligament suspended between a femoral and a tibial 
tunnel.  The mechanical behavior of the prosthetic was modeled using a Marlow 
hyperelastic constitutive relation fit to uniaxial tensile test data for the PVA and 
UHMWPE prosthetic.  The prosthetic was divided into three sections along the length of 
the cylinder; a femoral tunnel section at one end, adjacent to an intra-articular ligament 
section in the center, and a tibial tunnel sections at the other end. 
Tension was modified by extending or slackening the intra-articular section of the 
prosthetic prior to applying tie constraints to the bones, which were maintained in the 
same relative orientation in space.  To simulate the reconstructed knee in the fully 
osseointegrated state, rigid tie constraints permitting no relative motion were applied 
between the bone tunnel walls and the outer surfaces of the sections of the prosthetic 
surfaces lying within the tunnels after the application of extension or slack.  Tensions 
were reported with the knee at 30° flexion, an angle at which grafts are routinely 
tensioned and attached during reconstruction.[40-41] 
Prosthetic reconstruction models were created with the femoral tunnels in two 
different orientations.  The first orientation was with the femoral tunnel drilled transtibially 
with the knee at 90° of flexion, resulting in a more vertical placement at approximately 
the 11 o’clock position.  The other orientation was a more lateral placement at 
approximately the 10 o’clock position consistent with a reconstruction in which the 
femoral tunnel is drilled from an auxiliary anteromedial portal adjacent to the patella with 





Figure 5.1   Coronal and sagittal views of transtibial (A) and anteromedial (B) 
reconstructions.  
Reconstructions were evaluated kinematically and compared in terms of anterior 
laxity, rotational stability, and stress concentration.  Anterior laxity was evaluated by 
measuring the amount of ATT in response to an applied 134-N (30 lbs) anterior tibial 
load as in the physical study by Yagi et al. to simulate a clinical evaluation with an 
arthrometer. [4, 40]  Rotational stability was assessed by measuring the anterior 
displacement in response to 10-Nm valgus torque combined with 4-Nm internal torque 
applied to the tibia as to simulate the pivot shift test.[4]  Simulated anterior laxity and 
rotational examinations were executed with the knee at 0° and 30° flexion with the femur 
held stationary.    The evolution of stress concentrations within the prosthetic were 
evaluated over the course of the knee flexion from 0° to 90°. 
5.2.2 Model validation 
The model was validated by comparing outputs from the simulated ACL-intact 
and ACL-deficient controls against physical experimental data from the literature.  The 
anteromedial bundle(AMB) and posterolateral bundle (PLB) length changes were 
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measured over the course of flexion to extension along with the resultant force 
generated within the ACL in response to passive knee flexion. The controls were also 
tested for anterior translational laxity and rotational stability and compared to physical 
experimental results from the literature.   
5.2.3 Kinematic evaluations of reconstructed knees  
The kinematic evaluation of knees reconstructed with the prosthetic ACL 
proceeded as follows.  In Study 1, the objective was to determine if ACL primary function 
could be achieved using the prosthetic ligament in our model.  For each femoral tunnel 
orientation, the tension of the intra-articular segment of the prosthetic was adjusted to 
determine if an acceptable fit to the anterior laxity of the intact knee could be achieved 
and to determine the ideal level of tension.  Then, in Study 2, the sensitivity to changes 
in tension were examined in more depth to define an acceptable range for placement.  
The intra-articular aspect was extended and slackened in 1 mm increments up to 5 mm 
in each direction from the ideal tension found in Study 1 prior to attachment, with each 
perturbation tested for anterior laxity.  Next, in Study 3, the effect of orientation was 
examined in more depth to determine if one orientation demonstrated any superiority 
over the other.  Rotational stability and stress concentrations in the device over the 
course of the knee flexion from 0° to 90° were compared in prostheses installed at the 
ideal tension from Study 1 in the transtibial and anteromedial portal drilled femoral tunnel 
orientations.  Finally, Study 4 focused on the effect of toe region by measuring the 
anterior laxity and stress concentrations on simulated reconstructions using nonlinear 
and linear prostheses.  The stiffness of the linear material was selected as the average 
stiffness of the nonlinear material over the functional force range of the native ACL, from 




Figure 5.2   The single-axis force versus strain behavior for the nonlinear and 
linear prostheses tested shown alongside that of the native ACL.[1, 6]  Curves are 
shown up to 700 N force. 
5.3 Results 
5.3.1  Validation 
AMB and PLB length changes as well as ACL resultant forces over the range of 
flexion to extension were observed to fall within the experimentally determined normal 
range.[43-45]  These measurements together provided assurance that the imposed knee 
motion, the locations of each of the ACL bundle footprints, and the initial strains in each 

























Figure 5.3   Simulated AMB and PLB length changes shown alongside 
experimental results from Amis and Dawkins.[43]  Error bars represent one 
standard deviation for the experimental data. 
 
Figure 5.4   Simulated resultant force as a function of flexion angle shown 
alongside experimental results from Wascher et al.[44]  Error bars indicate the 
approximate range of values reported from the experimental data. 
ATT measured in the simulations on the controls were found to closely match 
with physical experimental data from a biomechanical study within one standard 

























































tibial translation to approximately 5 mm and 7 mm, respectively. Without the ACL, 
translation increases to approximately 13 mm and 20 mm.  The rotational behavior, 
evaluated with the simulated pivot-shift test on the controls was also found to produce 
the same trend as observed with the physical data.[4]  As shown in Figure 5.6, in both 
the experimental and simulated results, ATT in response to combine rotary loading was 




Figure 5.5   Simulation and experimental measurements of ATT in response to 
134-N anterior tibial load applied to ACL-intact and ACL-deficient knees.  
































Figure 5.6   Simulation and experimental measurements of anterior tibial 
translation in response to combined rotary loading of 10-Nm valgus torque and 4-
Nm internal tibial torque.  Experimental results are shown as mean ± standard 
deviation from Zantop et al.[4] 
5.3.2 Study 1: Ideal tension for restoration of anterior laxity 
Anterior laxity close to the level of the native ACL could be achieved using the 
prosthesis in both the transtibial and anteromedial orientations as shown in Figure 5.7.  
For the transtibially oriented prosthetic, the ideal tension, that which most closely 
matched the anterior laxity of the native ligament, was found to be 10 N at 30° flexion.  
This level of tension was achieved by extending the prosthetic by 0.5 mm prior to bone 
attachment.  For the anteromedially oriented prosthetic, the ideal tension at 30° flexion 
was found to be 0 N with no slack.  The anterior laxity was very similar in both 


































Figure 5.7   ATT in response to 134-N anterior tibial load in simulated transtibial 
and anteromedial prosthetic reconstructions with the ideal tension of 10 N for 
transtibial and 0 N for anteromedial implantations shown with simulated ACL 
intact and deficient controls. 
5.3.3 Study 2: Effects of changes in tension on anterior laxity 
In both orientations, tightening or loosening the device by up to 2 mm relative to 
the ideal level of tension found in Study 1 resulted in anterior laxity falling within 
approximately one standard deviation of the average intact knee or autograft 
reconstructions.[40]  In the transtibial orientation, extending the device by 2.5 mm prior 
to attachment tightened the prosthetic to a tension of about 100 N at 30° flexion.  
Restoration of function was attainable with the graft installed with somewhere between 






























Knee flexion angle (degrees)








Figure 5.8   ATT in response to 134-N anterior tibial loading with prosthetics 
placed at varying levels of extension and slack in the transtibial orientation shown 
alongside simulated ACL-intact and ACL-deficient controls.  The shaded area 
covers the range within one standard deviation of the intact knee and currently 
accepted ACL replacements from an experimental study by Yagi et al.[40] 
Alternatively, in the anteromedial portal drilled orientation, the range yielding 
results within one standard deviation of currently accepted replacements was from an 
installation tension as high as 40 N to as low as 0 N with up to 2 mm of slack at 30° 
flexion.   In general, installation of a graft with excessive tension results in over-
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Figure 5.9   ATT in response to 134-N anterior tibial loading with prosthetics 
placed at varying levels of extension and slack in the anteromedial orientation 
shown alongside simulated ACL-intact and ACL-deficient controls.  The shaded 
area covers the range within one standard deviation of the intact knee and 
currently accepted ACL replacements from an experimental study by Yagi et 
al.[40] 
Table 5.1   Range of tensioning for prosthetic placement resulting in restoration of 
anterior tibial restraint within one standard deviation of the native ACL and 











Transtibial 1.5 mm slack  
(0 N) 
0.5 mm extension  
(10 N) 
2.5 mm extension  
(100 N) 
Anteromedial  2 mm slack  
(0 N) 
0 mm extension  
(0 N) 
2 mm extension  
(40 N) 
5.3.4 Study 3: Effect of tunnel orientation on rotational stability and stress 
concentrations 
The simulated pivot shift test confirmed previous reports that ACL replacements 



































2 mm slack (0 N)
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versus transtibially oriented replacements.[27-28]  As shown in Figure 5.10, the ATT in 
response to combined valgus and internal tibial torques was reduced by close to 2 mm, 
a decrease of 23% to 35%, using the anteromedial orientation.  
 
Figure 5.10  ATT in response to combined rotary loading of 10-Nm valgus torque 
and 4-Nm internal tibial torque on simulated transtibial and anteromedial 
prosthetic reconstructions shown alongside simulated ACL-intact and ACL-
deficient controls. 
At the ideal installation tension, the prostheses in both orientations were 
subjected to passive knee flexion from 0° to 90° to analyze and compare stress 
concentrations produced in the devices.  In both orientations the greatest stress 
concentrations arose near the femoral tunnel exit with the knee at full extension.  This 
was the angle of knee flexion and location along the length of the device where the 
prosthetic was subjected to the highest angle of bending.  The greatest stress 
concentration occurred at the outermost radius of the bend.  Maximum stress in the 
transtibial oriented prosthetic was found to be 29.5 MPa, almost 50% greater than in the 
anteromedial portal oriented prosthetic, measured as 20.5 MPa.  The increase was also 
correlated with a greater prosthetic bending angle up to 90°, in the transtibially oriented 
device versus only about 60° for the anteromedially oriented device.  At 30°, 60°, and 
































and 4.8 MPa, compared to 6.9, 5.5, and 8.4 MPa in the anteromedial device, 
respectively.  The maximum stress arising in either orientation was well below the 
ultimate strength of the prosthetic, measured experimentally as greater than 65 MPa, 
thereby indicating a low risk of rupture. 
 
Figure 5.11  Maximum principal stresses in the device occurring at full extension 
in the transtibial (TT) and anteromedial (AM) orientations.  Inset shows maximum 
prosthetic bending angle in both orientations, which occurred at full knee 
extension. 
5.3.5 Study 4: Effect of toe region presence 
 The presence of the low stiffness toe at low strains was evaluated to determine if 
this nonlinearity in the mechanical behavior of the prosthetic ligament provided any 
advantage over a device with linear elasticity.  In both orientations, the placement 
tension of both the linear and nonlinear prostheses could be adjusted such that 
restoration of anterior laxity close to the native ACL could be achieved; therefore, 




Figure 5.12  Simulated results comparing ATT produced in response to a 134-N 
anterior tibial load in knees reconstructed with linear and nonlinear prosthetic 
ACL.  Results are shown alongside simulated ACL-intact and ACL-deficient 
controls.  
Differences were observed in the stress concentrations in the prosthetics as the 
knee was flexed from 0° to 90°.  In both implant orientations and at all tested flexion 
angles, the presence of the toe region was found to reduce the maximum principle 
stress from as little as 10% to as much as 200%.  The greatest maximum stress incurred 
over the range of flexion consistently arose at full extension.  Toe presence reduced the 
maximum stress at full extension by about 10% in the transtibial orientation and 30% in 
the anteromedial portal drilled orientation.  This reduction in stress would provide an 
advantage in terms of prolonging the fatigue life of the structure, demonstrating that 
nonlinearity, specifically the presence of a low stiffness toe at low strain, would be a 
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Figure 5.13  Maximum principle stresses arising in linear and nonlinear 
prosthetics in the transtibial orientation over the range of knee flexion from 0° to 
90°.  
 
Figure 5.14  Maximum principle stresses arising in linear and nonlinear 





























































The kinematic simulation used here demonstrated that a non-linearly elastic 
prosthetic possesses adequate mechanical properties to restore primary ACL function.  
With the device installed at the ideal tension, anterior tibial restraint was similar in the 
transtibial and anteromedial portal drilled tunnel orientations, with both capable of 
providing a close match to the native ACL.  Ideal tension for the transtibially oriented 
graft was found to be 10 N, slightly greater than the ideal value of 0 N for the 
anteromedially oriented graft; however, several millimeters of deviation either way from 
the ideal resulted in acceptable restoration of anterior tibial restraint similar to the 
currently used grafts.   
Though both orientations were similar in terms of resistance to anterior tibial 
loading, differences emerged upon assessment of rotational stability and stress 
concentrations.  The anteromedially oriented prosthetic was found to provide better 
rotational stability, a result consistent with previous physical experiments on 
reconstructions with biological grafts.[4, 28]  Additionally, the maximum stress within the 
device was significantly lower using the anteromedial orientation than with the transtibial 
orientation.  Taking into account only these measures, the anteromedial portal drilled 
orientation performed better; however, the transtibial orientation was still acceptable in 
terms of kinematics and may provide procedural or other advantages not herein 
addressed. 
With regards to the design of the mechanical behavior, the inclusion of a low 
stiffness toe region at small strains, as observed with the native ACL, was shown to be 
advantageous.  Relative to a purely linearly elastic ACL replacement, the presence of a 
toe region reduced stress concentration during knee motion while providing the same 
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level of function in terms of anterior laxity.  Greater stresses would theoretically increase 
the rate of fatigue and shorten the service life of the device.    
Several finite element analyses have been used in recent years to kinematically 
evaluate different aspects of ACL reconstruction.  The earliest reported was a study by 
Suggs et al. in 2003 in which grafts of varying stiffness corresponding to the ACL and 
bone-patellar tendon-bone grafts were installed at two levels of tension and compared in 
terms of anterior laxity.  In that study, the grafts were modeled as nonlinear springs 
providing no information on stress concentrations.[46]  A finite element study by Au et al. 
focused on the stress concentrations in the bones and how they were affected by tunnel 
placement.[47]  Peña et al. evaluated the effects of the stiffness of bone-patellar tendon-
bone, gracilis, and quadrupled semitendinosus grafts and initial graft tension on anterior 
laxity and stress concentrations using continuum models for the grafts.[48]  A later study 
by the same group also compared tibial and femoral tunnels drilled at different angles 
also in terms of anterior laxity.[49]  Rotation (though not translation) was evaluated in 
one finite element analysis by Ramaniraka et al. which compared single bundle, double 
bundle, and extra-articular reconstructions.[50]  Some distinguishing features of this 
study compared to previous simulated kinematic evaluations include the new material 
behavior of the PVA and UHMWPE prosthetic, the evaluation of the prosthetic with the 
toe versus the prosthetic with linear behavior, and the evaluation of stress concentration 
and rotation in transtibial and anteromedial drilled tunnel orientations.  Anterior 
translation, rotation, and stress concentrations were evaluated together to give a more 
complete understanding of the kinematic and functional effects of each variation. 
The simulation had several limitations related to the differences from the in vivo 
case introduced with the simplifications and assumptions made when building the model.  
The models were created to simulate the fully osseointegrated case by applying rigid tie 
129 
 
constraints between the bone tunnels and the outer surfaces of the sections of 
prosthetics lying within the bone tunnels.  Therefore, events occurring prior to full 
osseointegration and any relative motion between the bone tunnel and tunnel sections 
were not modeled.  For example, in the immediate post-operative term, the prosthetic is 
secured to bone tunnels using one of the many types of initial fixators which vary widely 
in terms of size, placement location, securing method, pullout strength, and stiffness.[51-
52]  In the early stages, the restraint provided by an ACL replacement might not be 
constant due to several factors including changes in fixation and bone properties, graft 
healing and viscoelastic effects, as well as the progression of osseointegration, which 
were not accounted for in this study.[14, 53]  These changes obfuscate the relationship 
between the initial graft tension and the long-term post-osseointegration tension 
evaluated in the study.  To reconstruct the ligament in a manner in which the ACL 
replacement is tensioned to the level evaluated in this study, it might be necessary to 
apply greater tension at the time of installation.  The amount of over-tensioning required 
would be dependent upon the aforementioned changes and has yet to be quantified. 
The tie constraints and how they were applied between the bone tunnel and 
prosthetic had an effect on the results.  For example, the shape of the bone tunnel exit 
may have bumps or irregularities that would directly affect the stress concentrations 
around the contact location on the prosthetic.  The tunnel exit shapes should have some 
degree of variation with each patient including the patient from which the current model 
was derived; therefore, stress concentrations arising due to bone tunnel exit shapes 
were noted as such and not modeled.  Regardless, it was observed that while some 
stresses arose at the bone tunnel edges, they were small relative to the peak stress 




Another limitation of the study was the modeling of the prosthetic as a single 
solid cylinder.  A more realistic and ligament-like design might be a fibrous structure 
consisting of many smaller filaments.  The stresses arising due to bending in a single 
larger radius cylinder are greater than in a construct of individual smaller cylinders since 
the stress increases with the distance from the neutral plane within each cylinder.  
Therefore, the value reported for the stresses are numerically representative of a solid 
cylindrical prosthetic; however, the results are still useful and valid for comparing relative 
stress concentrations in devices with different insertion techniques. 
5.5 Conclusion 
The kinematic model demonstrated that the prosthetic was capable of restoring 
the primary function of the ACL in either orientation when installed within a specific 
range of tension.  Additionally, it was shown that installation using the anteromedial 
orientation resulted in better resistance to rotational loading and reduced stress 
concentrations.  Finally, it was also shown that toe presence reduced stress 
concentrations.  The computational results obtained provide evidence for the potential of 
a non-linearly elastic prosthetic as a promising alternative to biological grafts currently 
used for ACL reconstruction, giving some justification for further investigation.  
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CHAPTER 6   Conclusion 
6.1 Summary and significance 
 Each year, approximately 175,000 ACL reconstructions are performed in the 
United States, at a total cost exceeding $2 billion.[1-3]  Biological tissue grafts are the 
current standard replacement option used for ACL reconstruction and have generally 
been successful at restoring knee stability and enabling patients to return to normal 
levels of activity.[4-6]  Regardless, persistent problems including pain and loss of 
function at the donor site when using autografts and disease transmission risk, 
increased knee laxity, and lack of availability with allografts would make a prosthetic 
alternative advantageous.[6-9]  Additionally, a prosthetic alternative would eliminate the 
need for the harvest operation for autografts and the need for procurement of allografts 
which would, in turn, provide significant savings in terms of operation times and costs.[9]    
Several prosthetics have come and gone over the past 30 years; however, 
design insufficiencies have prevented these devices from gaining widespread 
acceptance.[6]  Problems with past devices include lack of biocompatibility and 
generation of immunogenic wear particulate as well as susceptibility to creep and fatigue 
several years after implantation.[6]  New biomaterials, improvements in orthopedic 
surgery, and better understanding of knee biomechanics may enable a next-generation 
prosthetic that is suitable for ACL replacement. 
 Design control concepts were applied in our attempt to develop a functional 
prosthetic ACL.  Comprehensive design inputs were specified consistent with the 
demands of knee joint, with performance at least to the level of currently accepted 
replacements, taking into account the failure modes of previous devices.  A risk analysis 
was performed and appropriate verification tests were devised to ensure safety and 
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efficacy.  A design with several unique and novel features was developed and subjected 
to verification testing. 
The proposed design is a composite structure consisting of polyvinyl alcohol 
(PVA) and ultrahigh molecular weight polyethylene (UHMWPE), with two tunnel sections 
to be placed in the bone tunnels on each side of an intra-articular ligament-replacing 
section.  PVA and UHMWPE were selected based upon a good record of 
biocompatibility as well as mechanical strength and stiffness suitable for ACL 
replacement.[10-13]  The rope pattern designed for the intra-articular section consisted 
of 12 UHMWPE threads braided around a core of 16 PVA cords with a helix angle 
between 40° and 50°.  The structure had strength double that of the native ACL and 
greater than earlier devices such as the Dacron, Leeds-Keio, and ABC prosthetic 
ligaments, which were susceptible to failure from rupture in vivo.[6, 14]  The design 
provided stiffness within the range of the native ligament and currently accepted 
replacements over the physiologically relevant force and strain range.[15-17]  A novel 
feature engineered to extend the fatigue life is the presence of a low stiffness toe at low 
strain as observed with the native ligament.[18-19]  Toe region presence was shown in a 
kinematic simulation to reduce stress concentrations over the course of knee flexion.  
The design was physically tested for fatigue and creep and performed satisfactorily up to 
1 million cycles at which point testing was stopped. 
The tunnel sections were designed with several novel features to support early 
fixation and optimize conditions for long term osseointegration.  Porosity allows for bony 
ingrowth while a tubular shape allows full circumferential contact between the device and 
the tunnel and provides an open space inside the tube for placement of a screw fixation 
at the aperture or addition of osteoinductive substances such as calcium phosphates, 
growth factors, or bone mulch.  The addition of loops at the far ends of the tunnel 
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sections enables compatibility with suspensory fixations such as buttons, crosspins, and 
staples providing more implantation options for the surgeon.  PVA is hydrophilic and can 
swell in the tunnel improving the fit by increasing pressure against the bone tunnel wall.  
A coating containing calcium phosphate or another osteoinductive material may be 
applied to the outer surface of the tunnel sections to promote bony incorporation and 
healing. 
An innovative computational kinematic evaluation tool was developed and 
validated in order to assess functionality of the device in the knee and determine the 
effects of placement tension and femoral tunnel orientation.  Common clinical knee 
diagnostic assessments were simulated including the anterior drawer test and the pivot 
shift test to measure outcomes in terms of anterior laxity and rotational stability.  The 
device provided good restraint to anterior tibial translation in both the transtibial and 
anteromedial portal drilled tunnel orientations; however, the anteromedial portal drilled 
orientation provided superior rotational stability and reduced the maximum stress.  The 
tension at which the device was placed was found to be a critical factor for functional 
restoration, with a window of about 4 mm of extension providing results in line with the 
currently used grafts.   
The reviews and studies presented in this thesis were performed to look at each 
of the major aspects of the problem of how to develop a prosthetic ACL and gather 
adequate preclinical data to assess feasibility, safety, and efficacy to support the 
progression to the next stage of in vivo testing.  The results of the performed ex vivo 
verification and validation tests indicate that the composite PVA and UHMWPE design 
satisfies the critical design inputs and may be a promising alternative to biological grafts 
warranting further investigation. 
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6.2 Alternative solutions 
 In addition to the specific functional design upon which we have converged, it 
may be worthwhile to note other alternative design directions which may have also led to 
workable solutions.  Materials selection was based upon a demonstrated history of 
biocompatibility and high tensile strength to avoid the observed failure modes of 
previous devices.  Metals such as titanium or other polymers such as polyurethanes also 
demonstrate good biocompatibility and could perhaps be substituted for the UHMWPE 
with quantity adjusted to provide adequate strength.  The advantages of hydrophilicity 
and the ability to swell in the bone tunnels might be provided by another material other 
than PVA; however, most other hydrogels with a history of implantation possess inferior 
strength or have been observed to degrade in vivo.   
Additionally, the choices with regards to rope design are inexhaustible, possibly 
involving a combination of pattern types, hierarchical arrangements, and geometrical 
parameters.  The braid type for the current design was selected based upon the 
comparison of several simple types of patterns and the application of general rope 
design principles, yet it is possible that some other pattern may also be capable of 
reproducing a ligament-like tensile response.  However, it is also worth noting that more 
complex patterns with more points at which strands crossing over each other are usually 
more susceptible to wear damage and have inferior fatigue life.[20]   
Other variations are also possible using the same materials and rope pattern as 
the current design.  For example, more yarns of UHMWPE, each with a smaller 
diameter, or fewer yarns, each with a greater diameter could have been used.  These 
changes may have an effect on the static and long-term behavior of the construct, but 
were not studied in the mechanical design analysis since a satisfactory result had been 
attained.    
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6.3  Limitations 
 There were several factors limiting certain aspects of the design and evaluation 
process.  All the samples created for testing were braided or twisted in different patterns 
by hand with nothing more than a braiding disk and were, therefore, not as uniform as 
they would have been if manufactured with a braiding or winding machine.   Additionally, 
one of the challenges associated with the fatigue study was the requirement that the 
samples remain submerged under water for the duration of the test as cyclic loading was 
applied and force and strain were recorded.  Large clamps or capstans capable of 
gripping the full size samples could not fit inside the cylindrical chamber used to contain 
the water; therefore, smaller samples with only half the quantity of PVA were tested.  A 
larger test chamber would enable better gripping for testing of full size samples.  Time 
constraints limited testing to one million cycles, leaving the number of cycles to failure 
yet to be determined.  Additionally, the long-term tests were only performed in tension, 
leaving other potential degradation modes such as bending and abrasion to be 
evaluated in a future study. 
 The kinematic evaluation had to be simplified due to incomplete knowledge of the 
biomechanical behavior of the knee.  The most important structures contributing to knee 
kinematics, the collateral and cruciate ligaments and menisci, were included in the 
simulation and modeled with anatomically accurate attachments, tensile behavior, and 
initial strains defined using biomechanical data from the literature. Other structures were 
not included such as the patellar tendon and patella, the joint capsule, and the muscles, 
since they had similarly been neglected in earlier models and data regarding their 
behavior and effect on knee kinematics were more variable, less significant, and 
underdefined in the literature.[21-24]  The model was validated using several different 
kinematic measurements to provide assurance that the simulated tests would provide 
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meaningful results.  Nevertheless, more complete physical data would be required to 
build and validate a more robust model with a confidence level great enough to predict 
behavior at a wider range of knee flexion angles and in response to more complex 
loading conditions.  Another weakness of the kinematic study was the fact that only one 
knee was used to create the model.  Several orthopedic surgeons who routinely perform 
ACL reconstructions examined the model and assured that the knee was typical with no 
abnormalities, yet an averaged model from several knees may have been superior.  
Better yet, multiple models created from a range of knees would be useful to assess 
variability of the results. 
6.4  Future directions 
 The preclinical benchtop and simulated verification results obtained support the 
feasibility of the composite prosthetic ACL. Long-term cyclic loading tests, monotonic 
creep tests, and cyclic bending tests should be executed using video strain 
measurements to acquire a better quantification of the elongation to expect in vivo, 
separated from the effects of clamp slippage.  Design inputs which have yet to be 
evaluated with benchtop testing include bending fatigue and abrasion.  For bending 
fatigue testing, the FDA recommends imposing combined bending and loading typical of 
normal activity which might vary depending on the tunnel orientation.[25]  Abrasion 
testing, utilizing cadaver bone or different grades of abrasive material, can be combined 
as a part of the bending fatigue test by simulating the conditions at the attachment sites 
and places on the device where rubbing against the bone is likely occur.[25]  Although a 
design has been envisioned and proposed for the tunnel sections, it may require 
additional engineering and verification testing of fixation strength and stiffness using 
cadaverous bone.[25]  Cyclic loading might also be applied to determine if the fixation is 
susceptible to loosening.   
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Additionally, the FDA requires data to ensure that the device does not present 
adverse toxicological effects.  This may be provided from prior clinical usage history and 
component toxicology information from the literature or with preclinical biological testing.  
Hazard identification information should be provided from tests for pyrogenicity, 
hemolytic potential, acute toxicity and intracutaneous irritation, cytotoxicity, genetic 
toxicity, and immunological potential.[25]  
Next steps would include animal and clinical studies.  Humans are the only 
species that is both bipedal and plantigrade; therefore, from a biomechanical standpoint, 
the human knee is unique and has no ideal animal model for assessment of functional 
restoration.[26]  Regardless, the FDA recommends animal studies to assess histological 
and immunological reaction to the device and particulate, material degradation, 
abrasion, damage, particulate migration, fixation strength, and fibrous ingrowth.[25]   
A first-in-man study would yield additional information regarding osseointegration, 
functional restoration, and implant survivability in humans.  Factors lowering risk include 
the demonstrated biocompatibility of the constituent materials and the fact that in the 
case of mechanical failure, the device could be surgically removed and secondary 
replacement would be possible with a biological graft.  In the United States, a first-in-
man study, like other clinical trials, requires approval of the investigational plan by an 
Institutional Review Board (IRB) and an Investigational Device Exemption (IDE) approval 
from the FDA which is based upon adequate preclinical data.  In Europe, first-in-man 
studies can commence with the approval of a local Ethics Committee (EC) and upon 
notification of the National Authority.  Prosthetic ACLs have been classified by the FDA 
as a Class III medical device requiring full premarket approval (PMA) based upon proven 
safety and efficacy prior to market entry.[25]  From a clinical standpoint, the availability 
of a reliable prosthetic alternative to biological grafts would reduce operation times, 
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accelerate the recovery period, and improve outcomes by the preclusion of donor site 
morbidity, thereby providing significant advantages for both patients and surgeons. 
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